Pharmacognostical, Phytochemical, Evaluvation of Sedative and Hypnotic Activity on Seed Aril of Myristica Malabarica Lam by Premkumar, C
PHARMACOGNOSTICAL, PHYTOCHEMICAL, EVALUVATION OF SEDATIVE AND 
HYPNOTIC ACTIVITY ON SEED ARIL OF Myristica malabarica Lam., 
A dissertation submitted to 
THE TAMILNADU Dr. M.G.R MEDICAL UNIVERSITY 
CHENNAI-600 032 
 
 
 
In partial fulfilment of the requirements for the award of degree of 
MASTER OF PHARMACY 
IN 
PHARMACOGNOSY 
 
Submitted by 
C. PREM KUMAR 
REG. NO: 261520656 
 
Under the guidance of 
Dr. R. Radha M.Pharm., Ph.D., 
 
 
 
 
 
Department of Pharmacognosy 
College of Pharmacy 
Madras Medical College 
Chennai-600 003. 
MAY 2017 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATE 
 
 
 
 This is to certify that the dissertation entitled "PHARMACOGNOSTICAL, 
PHYTOCHEMICMISTRY, EVALUVATION OF SEDATIVE AND HYPNOTIC 
ACTIVITY ON SEED ARIL OF Myristica malabarica Lam.," submitted by Reg. No: 
261520656 in partial fulfilment of the requirements for the award of the degree of MASTER 
OF PHARMACY IN PHARMACOGNOSY by The Tamil Nadu Dr. M.G.R Medical 
University, Chennai is a bonafide record of work done by him in the Department of 
Pharmacognosy, College of Pharmacy, Madras Medical College, Chennai-600003 during 
the academic year 2016-2017 under the guidance of DR. R. RADHA, M.PHARM., Ph.D., 
Department of Pharmacognosy, College of Pharmacy, Madras Medical College, Chennai-
600003. 
 
 
 
 
    DR .A. JERAD SURESH  M.Pharm., Ph.D., MBA., 
    Principal, 
    College of Pharmacy, 
    Madras Medical College, 
    Chennai - 600003. 
 
 
Place: Chennai-03 
Date: 
 
 
 
 
 
 
 
 
 
DR. R. RADHA M.Pharm., Ph.D., M.B.A., 
Professor and Head, 
Department of Pharmacognosy, 
College of Pharmacy, 
Madras Medical College, 
Chennai-600003. 
 
CERTIFICATE 
 
 
 This is to certify that the dissertation entitled "PHARMACOGNOSTICAL, 
PHYTOCHEMICMISTRY, EVALUVATION OF SEDATIVE AND HYPNOTIC 
ACTIVITY ON SEED ARIL OF Myristica malabarica Lam.," submitted by Reg. No: 
261520656 in partial fulfilment of the requirements for the award of the degree of MASTER OF 
PHARMACY IN PHARMACOGNOSY by The Tamil Nadu Dr. M.G.R Medical University, 
Chennai, is a bonafide record of work done by him in the Department of Pharmacognosy, College 
of Pharmacy, Madras Medical College, Chennai-600003 during the academic year 2016-2017 
under the guidance of DR. R. RADHA  M.PHARM., Ph.D., Department of Pharmacognosy, 
College of Pharmacy, Madras Medical College,  Chennai-600003. 
 
 
 
      Dr. R. RADHA M.Pharm., Ph.D., M.B.A., 
 
Place: Chennai-03 
Date: 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
DEDICATED TO MY BELOVED 
PARENTS 
 ACKNOWLEDGEMENT 
 
I take immense pleasure in extending my gratitude to each and every one who was 
constantly encouraging me and The Almighty for guiding me with wisdom and support 
throughout my project work. 
 
I whole heartedly express my high esteem and deep sense of gratitude to respectable 
Dr. K. NARAYANASAMY, M.D, D.M, DEAN, Madras Medical College, Chennai, for 
providing me all the facilities and support during the period of academic course work. 
 
In taking great pleasure to thank our beloved Principal DR.A. JERADSURESH, 
M.Pharm.,Ph.D.,M.B.A., College of Pharmacy, Madras Medical College, for providing lab 
and administrative facilities to carry out  the project work. 
 
I take this opportunity with profound privilege and great pleasure in  expressing my 
deep sense of gratitude to my respected Guide DR.R.RADHA M.Pharm.,Ph.D., professor 
and Head, Department of Pharmacognosy, College of Pharmacy, Madras Medical College, 
Chennai -03, for her gracious guidance, innovative ideas, with constant inspiration, 
encouragement, suggestions and infinite help throughout my research work. I greatly thank 
her valuable support and endless consideration of my project work. 
 I take great pleasure in acknowledging my sincere thanks to all the staff members 
DR.P.Muthusamy M.Pharm.,Ph.D.,B.L., DR.R.Vijayabharathi M.Pharm.,Ph.D., 
DR.R.Vadivu M.Pharm.,Ph.D., and B.Kumudhaveni M.Pharm, of the Department of 
Pharmacognosy, College of Pharmacy, Madras Medical College, Chennai -03 for their 
valuable suggestions and moral support. 
  I extend my gratitude to the lab assistants Mrs. Lakshmi and Mrs. Kumudha of 
the Department of Pharmacognosy, College of Pharmacy, Madras Medical College, 
Chennai-03 for their support and help during project work 
             I extend my gratitude to Dr.Seenivelan, B.V.sc., Special veterinary officer  and 
Mr.Kandhasamy and Mr.Kumar Assistants of Animal Experiment House, Madras 
Medical College, Chennai-03 for providing animals to carryout Pharmacological studies. 
                 I acknowledge my sincere thanks P. Sathiyarajeswaran, Assistant director of 
Siddha Central Reasearch Institute, Arumbakkam, Chennai, for the authentication of the 
plant material. 
             I express my special thanks to my fellow classmates Shalini .K, M. Elayasuriyan, 
M. Raj Kumar, A. Babu and my other Batch mates for their encouragement and support 
during project work. 
                I express my hearty thanks to my department junior Anand for the help in 
microscopical works and all other juniors for their support and help in completion of my 
project.  
               I also extend my thanks to my friends C. Balachandar, S.Deepan, Dinesh Kumar 
and all those who helped me directly or indirectly during this project. 
 
               With all my love I extend my hearty gratitude to my Mother and Father for 
expressing their love, care, prayer, encouragement and support in all my endeavours 
throughout life. 
 
CONTENTS 
 
 
S.No                                    TITLE PAGE 
NO 
1 INTRODUCTION 1 
2 REVIEW OF LITERATURE 13 
3 PLANT PROFILE 19 
4  
RATIONALE FOR SELECTION OF THE PLANT 
 
21 
5 AIM AND OBJECTIVE OF THE STUDY 22 
6 PLAN OF STUDY   23 
7 MATERIALS AND METHOD 
   24 
8 RESULTS AND DISCUSSION    52 
9 SUMMARY AND CONCLUSION       85 
10 REFERENCES       89 
11 ANNEXURE  
 
LIST OF TABLES 
 
Table 
No. 
Title 
Page.   
No. 
1 Traditional plants used as Sedative and Hypnotic drugs 12 
2 Morphological features of Seed aril 52 
3 
Histochemical colour reactions of Myristica 
malabarica 
56 
4 
 The Physicochemical analysis of the seed aril 
of Myristica malabarica 
57 
5 Qualtitative estimation of inorganic elements of 
Myristica malabarica 
58 
6 Quantitative estimation of inorganic elements of 
Myristica malabarica 
58 
7 
  Quantitative estimation of Heavy metals 
 
59 
8 Percentage yield of successive extracts of seed aril of 
Myristica malabarica. 
59 
9  Qualitative Phytochemical analysis 60 
10  Determination of Total Flavanoid content 61 
11  Determination of  Total phenolic content 62 
12  Determination of Total alkaloidal content 63 
13 Determination of Total Phytochemical content 
  
 
  
64 
14 Fluorescence characteristic powdered of samples at 
short UV and long UV 
64 
15 Fluorescence characteristic of extracts at short UV and 
long UV 
65 
16 Thin layer chromatography of various extract. 65 
17 Solvent system of HPTLC analysis 66 
18 HPTLC profile of extracts 68 
19 DPPH Radical Scavenging activity of various extract 
 
69 
20 Hydrogen peroxide Radical Scavenging activity of 
various   extract 
71 
21 Sedative activity using actophotometer 73 
22 Percentage decrease in Locomotor activity 74 
23 Potentiation of Hexobarbital induced sloe time for 
Hypnotic activity 
 
75 
24 Fractionation of ethanolic extract 77 
25 Thin layer chromatography of isolated fractions 78 
26 IR Interpretation 81 
27 GCMS analysis of Compound 1 83 
 
LIST OF FIGURES 
 
 
Figure
No. 
Title 
Page 
No. 
1   Sleep 3 
2   Types of sleep 4 
3   Sleep Disorder 5 
4   Whole Tree of M.M 15 
5   Trunk and Bark of M.M 15 
6   Branches of M.M 15 
7   Exudates of M.M 16 
8   Leaves of M.M 16 
9 
  Flowers of M.M 
17 
10 
  Fruit of M.M 
17 
11   Actophotometer 47 
12   Righting reflex 48 
13   Fresh fruit with seed aril 53 
14 
  Dried Seed Aril 
53 
15 
  TS of Myristrica malabarica 
54 
16   Oil Globules 55 
17   Fibres 55 
18   Cluster of stone cell 55 
19   Calcium oxalate crystal 55 
20   Vascular bundle 56 
21   Starch grains 56 
LIST OF FIGURES 
 
22   Total Flavonoid content 61 
23   Total Phenolic Content 62 
24   Total Alkaloid Content 63 
25   Benzene extract TLC 66 
26   Ethanol extract TLC 66 
27   Aqueous extract TLC 66 
28   HPTLC Finger Print Data 67 
29   HPTLC chromatogram for Myristica malabarica 67 
30   Histogram for Myristica malabarica Lam HPTLC   
data 
68 
31   DPPH Radical Scavenging activity of various 
extract 
70 
32   Hydrogen peroxide Radical Scavenging activity of 
various extract 
71 
33   IC 50 values of antioxidant activity of various 
extract 
72 
34   Percentage decrease in locomotor activity 74 
35   Percentage increase in sleep time 76 
36   TLC of Compound 1 80 
37   IR analysis of Compound 1 82 
38   FTIR analysis of Compound 1 82 
39   GCMS Analysis of Compound 1 83 
40   GCMS Analysis of Compound 1 with structure 84 
  
 
 
  
INTRODUCTION 
Introduction 
Department of Pharmacognosy, COP, MMC                                                              1 | P a g e  
1. INTRODUCTION 
              In our modern civilization we are living in a stressful and disarray environment 
where sleep cycles are easily disturbed and leads to sleep disorders. Sleep disorders such 
as Insomnia, Narcolepsy, Parasomnia, Sleepwalking, Night terror, etc., arises due to 
inadequate or lack of sleep1. Medicines such as Benzodiazepines and barbiturates are 
commonly prescribed to treat sleep disorders. However these drugs on the long run causes 
undesirable side effects and various complication such as drug dependence, disorientation, 
amnesia, impaired psychomotor activity and drug withdrawal symptoms2. In India 1 out of 
5 patients i.e. that is 20% of the patients suffer from sleep disorder3. Traditional medicinal 
system is based upon the natural resources such as plants, animals and minerals available 
in their locality. 
             India, a birthplace for many traditional medicinal systems which are still followed 
up to till date by majority of the population. This is due to the flourishment of wide variety 
of flora and fauna. Many medicinally valuable plants are native to Indian sub-continent. 
Yet much more plants are still are in investigation or lack detailed study.4 There is much 
potential in herbal studies. Since allopathic medicines have many undesirable side effects, 
modern civilization began to turn its head once again to natural method, i.e. traditional 
medicinal systems. According to WHO more or less 80% of the people relay to their own 
native traditional medicinal irrespective to their nation or advancement in modern science5. 
There is still a raise in demand to herbal medicines and people are turning back again to 
herbal remedy due to their no side effect or less cost. India has epic traditional system such 
as Ayurveda, siddha, unani, tribal, etc,..These traditional system are followed in India long 
back before the popularization of western allopathic medicinal system. The Ayurveda and 
siddha traditional system dates back several thousand years BC.  
1.1 HERBAL MEDICINE IN INDIA  
             India stands first among all the Asian countries in having the knowledge on 
traditional system related to the use of plant species and diversity of higher plant species, 
which is the reason for the use of herbs in different forms in alternative systems of 
medicine6. India has about 45,000 plant species. This huge number of medicinal plants 
species possess important role in health system. Among these, several thousand plants have 
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been claimed to possess medicinal properties. Although herbal medicine are used in various 
ailments, often these drugs are improperly used and only few of them have got scientifically 
documented. Hence plant drug need a detailed study in the light of modern medicine in 
bringing new herbal chemical entities.  
Origin7  
               Plants, animals and human beings have intimate biological relationships for their 
very basic needs like air, food, fire and fuel, since remote past. The primitive men during 
the course of their struggle in the forest under the circumstances of object poverty disease 
and hunger. To liberate themselves from these suffering they should have looked towards 
the nature (i.e.) plants and this inevitably led to trial and error experimentation and 
discovery of the healing properties of plants by using wild animals. As time went on, each 
tribe added the medicinal power of herbs in their area to its knowledge base. They 
methodically collected the information on herbs and developed well-defined herbal 
pharmacopeia. In 20th century, the pharmacopoeia of scientific medicine was derived from 
the herbal lore of native peoples. Many drugs commonly used today are of herbal origin. 
About 25% of the prescription drugs dispensed from plant material  
Importance   
               The natural to assume that plants were not only eaten for food but were also used 
as a source of medicine. Although written and pictorial records of herbalism cover no more 
than the past 5,000 to 6,000 years, archeologically records clearly show that the knowledge 
and practise of herbal medicine was highly developed long before the earliest written 
accounts known to us were made. Plants form the major healing powers in almost all 
ancient civilization like Egyptian, Chinese, India, Roman and Greek8.  
Foods and herbs as medicine 9 
               The majority of medicinal plants found in the world grow wild. As natural 
habitats worldwide are degraded, overexploited and destroyed, many plants species 
including medicinal plants face threats to their survival. It is becoming increasingly 
important to take care of the areas in which they grow and to share knowledge about their 
usefulness.  
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Involving local people from areas where the plants grow is crucial. In the India many 
people rely on plants and plant – products for food, medicine and shelter. We need to 
balance health first through proper nutrition with the help of herbs serving as special foods 
for both body and mind.   
Scientific approach to the herbal medicine10  
               The technology involving extraction, purification and characterization of 
pharmaceuticals from natural sources is a significant contribution to the advancement of 
natural and physical sciences. The rapid development of phytochemistry and 
pharmacological testing methods in recent years, new plant drugs is finding their way into 
medicine as a purified phytochemicals, rather than in the form of traditional galenical 
preparations. Phytopharmaceuticals or synthetic drugs derived from phytochemicals have 
to be ultimately incorporated in suitable dosage form which involves the knowledge of 
dispensing and preparative pharmacy, pharmaceutical technology and analysis.  
Pharmacognosy is a vital link between Ayurvedic and Allopathic systems of medicines. It 
provides a system wherein the active principles of crude drugs derived from natural origin 
can could be dispensed, formulated and manufactured in dosage forms acceptable to the 
Allopathic system of medicine 
1.2 DISEASE PROFILE 
                                 
Fig. 1 Sleep 
1.2.1 Sleep11: 
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              Sleep is a state of decreased awareness of environmental stimuli that is 
distinguished from states such as coma or hibernation by its relatively rapid reversibility. 
Sleeping individuals move little and tend to adopt stereotypic postures. Although sleep is 
characterized by a relative unconsciousness of the external world and a general lack of 
memory of the state, unlike people who have been comatose, we generally recognize when 
we feel sleepy and are aware that we have been asleep at the termination of an episode. 
              For clinical and research purposes, sleep is generally defined by combining 
behavioral observation with electrophysiological recording. Humans, like most other 
mammals, express two types of sleep: rapid eye movement (REM) and non-rapid eye 
movement (NREM) sleep. These states have distinctive neurophysiological and 
psychophysiological characteristics.  
Phases of Sleep12: 
 
Fig. 2 Types of sleep 
 NREM Sleep:  Also called as orthodox sleep, is characterized by decreased activation 
of the EEG; in infants it is called quiet sleep because of the relative lack of motor 
activity. It has four stages.  
 Stage 1 (Dozing): light sleep where you drift in and out of sleep and can be awakened 
easily. In this stage, the eyes move slowly and muscle activity slows. During this stage, 
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many people experience sudden muscle contractions preceded by a sensation of falling. 
 Stage 2 (Unequivocal sleep): eye movement stops and brain waves become slower 
with only an occasional burst of rapid brain waves. When a person enters. 
 Stage 3 (Deep sleep transition): extremely slow brain waves called delta waves are 
interspersed with smaller, faster waves. 
 Stage 4 (Cerebral sleep): the brain produces delta waves almost exclusively. Stages 3 
and 4 are referred to as deep sleep or delta sleep, and it is very difficult to wake someone 
from them. In deep sleep, there is no eye movement or muscle activity. This is when 
some children experience bedwetting, sleepwalking or night terrors 
 REM sleep: It derives its name from the frequent bursts of eye movement activity that 
occur. It is also referred to as paradoxical sleep because the electroencephalogram 
(EEG) during REM sleep is similar to that of waking. In infants, the equivalent of REM 
sleep is called active sleep because of prominent phasic muscle twitches. 
1.2.2 Sleep Disorder13-16: 
 
Fig. 3 Sleep Disorder 
           The sleep disorders are categorized into primary disorders (i.e. Dyssomnias and 
Parasomnias), those related to another mental disorder or to a general medical disorder, 
and those that are substance induced. 
Primary Insomnia Disorders: 
                  Primary insomnia is characterized by difficulty in initiating or maintaining 
sleep or by not feeling rested after an apparently adequate amount of sleep for at least 1 
month. It is characterized by excessive daytime worry about being able to fall or stay 
Introduction 
Department of Pharmacognosy, COP, MMC                                                              6 | P a g e  
asleep. Anxiety tends to perpetuate a vicious cycle of sleeplessness that is aggravated by 
worry about sleeplessness.  Primary insomnia disorders includes dyssomnias and 
parasomnias. The dyssomnias may occur due to intrinsic sleep disorders, extrinsic sleep 
disorders and disturbance of the circadian rhythm. 
i. Intrinsic Sleep Disorder 
A) Psychogenic Insomnisa: 
                    Psychogenic insomnia is characterized by increased mental tension (inability 
to relax, anxiety, brooding) and excessive concern about sleep itself. Sleep often improves 
in a new environment (e.g. on vacation). 
B) Pseudo Insomnia: 
                        Pseudo insomnia is a subjective feeling of disturbed sleep in the absence of 
objective evidence (i.e. normal polysomnography). 
C) Restless Leg Syndrome:  
                        Restless legs syndrome is characterized by ascending abnormal sensations 
in the legs when they are at rest (e.g. when the patient watches television, or before falling 
asleep) accompanied by an urge to move the legs. It is sometimes present as a genetic 
disorder with autosomal dominant inheritance. Periodic leg movements during sleep are 
repeated, abrupt twitching movements of the legs that may persist for minutes to hours. 
D) Narcolepsy: 
                        Daytime somnolence and frequent, sudden, uncontrollable episodes of sleep 
(imperative sleep), which tend to occur in restful situations (e.g. reading, hearing a lecture, 
watching television, long automobile ride. It may be associated with cataplexy (sudden, 
episodic loss of muscle tone without unconsciousness), sleep paralysis (inability to move 
or speak when awaking from sleep) and hypnagogic hallucinations (visual or acoustic 
hallucinations while falling asleep). 
E) Obstructive Sleep Apnea: 
                   Obstructive sleep apnea is characterized by daytime somnolence with frequent 
nocturnal respiratory pauses and loud snoring. Impaired concentration, decreased 
performance and headaches are also common. 
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ii. Extrinsic Sleep Disorder: 
                 Sleep may be disturbed by external factors such as noise, light, mental stress and 
medication use. 
 
iii. Disturbance of Circadian Rhythm: 
                   Sleep may be disturbed by shift work at night or by intercontinental travel (jet 
lag) 
iv. Parasomnias: 
                   These disorders include confusion on awakening (sleep drunkenness), 
sleepwalking (somnambulism), nightmares, Sleep myoclonus, bedwetting (enuresis), and 
nocturnal grinding of the teeth (bruxism). 
Secondary Sleep Disorders: 
i. Psychogenic Sleep Disorder: 
                      Depression (of various types) can impair sleep, though paradoxically sleep 
deprivations can ameliorate depression. Depressed persons typically complain of early 
morning awakening, nocturnal restlessness, and difficulty in starting the day.  
ii. Neurogenic Sleep Disorder: 
                    Sleep can be impaired by dementia, Parkinson disease, dystonia, respiratory 
disturbances secondary to neuromuscular disease (muscular dystrophy, acute coronary 
syndrome), epilepsy (nocturnal attacks), and headache syndromes (cluster headaches, 
migraine). Fatal familial insomnia is a genetic disorder of autosomal dominant inheritance. 
iii. Sleep Disorder Due to Systemic Disease:  
                     Sleep can be impaired by pulmonary diseases (asthma, COPD, angina 
pectoris, nocturia, fibromyalgia and chronic fatigue syndrome). 
1.2.3 Symptoms of Sleep Disorder17: 
i. Depression 
ii. Irritability or anxiety 
iii. Feeling as if sleep was unrefreshing (non-restorative). 
Introduction 
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iv. Experiencing excessive daytime sleepiness. 
v. General lack of energy. 
vi. Difficulty concentrating. 
vii. Mood and behavior disturbances such as irritability, aggression, and impulsive 
behaviors. 
viii. Difficulty concentrating. 
ix. Forgetfulness. 
x. Decreased performance at work or school. 
xi. Troubles in personal and professional relationships. 
xii. Having accidents at work or while driving fatigued. 
xiii. Decreased quality of life. 
xiv. Depression. 
1.2.4 Causes for Sleep Disorder18: 
 Psychological problems: depression, anxiety, stress. 
 Lifestyle habit such as smoking, caffeine, alcohol, napping and irregular sleeping 
patterns. 
 Medical conditions such as congestive heart failure or prostate enlargement. 
 Painful conditions, such as arthritis, shingles. 
 Genetics-Researchers have found a genetic basis for narcolepsy, a neurological 
disorder of sleep regulation that affects the control of sleep and wakefulness. 
 Aging-About half of all adults over the age of 65 have some sort of sleep disorder. 
It is not clear if it is a normal part of aging. 
 Medication side effects. 
 Chronic use of sedatives, which can cause light, broken sleep patterns. 
 Neurological disorders such as Alzheimer’s disease, dementia, delirium, 
Parkinson’s disease. 
 Not enough exercise. 
 Obesity; metabolic syndrome and diabetes. 
 Environment problems: Night noise and lights. 
 Night-time trips to the bathroom.  
Introduction 
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1.2.5 Pathophysiology of Sleep Disorder19: 
                      The physiological mechanisms regulating the sleep-wake rhythm are not 
completely known. There is evidence that histaminergic, cholinergic, glutamatergic, and 
adrenergic neurons are more active during waking than during the NREM sleep stage. Via 
their ascending thalamopetal projections, these neurons excite thalamocortical pathways 
and inhibit GABA-ergic neurons. During sleep, input from the brainstem decreases, giving 
rise to diminished thalamocortical activity and disinhibition of the GABA neurons. The 
shift in balance between excitatory and inhibitory neuron groups underlies a circadian 
change in sleep propensity, causing it to remain low in the morning, to increase towards 
early afternoon (middle siesta), then to decline again, and finally to reach its peak before 
midnight. 
                       As the margin between excitatory and inhibitory activity decreases with age, 
there is an increasing tendency towards shortened daytime sleep periods and more frequent 
interruption of nocturnal sleep. Imbalance between the excitatory and inhibitory 
neurotransmission with more shift toward excitatory system underlies many of the sleeping 
disorders. 
1.2.6 Management of sleep disorders20-25: 
➢ Non pharmacological Treatment. 
➢ Pharmacological Treatment. 
➢ Traditional Medicines. 
Non Pharmacological Treatment: 
Sleep hygiene 
                       The concept of sleep hygiene refers to practices, habits, and environmental 
factors that are important for getting sound sleep. The four general areas important to sleep 
hygiene are the circadian rhythm (24-hour cycle); aging; psychological stressors that cause 
mini-awakenings (in which the brain wakes up for just a few seconds); and substances such 
as nicotine, caffeine, and alcohol. 
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Cognitive behavioral therapy 
                        In this therapy, patients are taught improved sleep habits and relieved of 
counter-productive assumptions about sleep. Common misconceptions and expectations 
that can be modified Cognitive therapy can give people the proper information about sleep 
norms, age-related sleep changes, reasonable sleep goals, and the influence of naps and 
exercise. 
Sleep restriction therapy  
                 Sleep restriction therapy is based on the belief that excess time in bed makes 
sleep problems worse. SRT consists of limiting a person’s time in bed to only that time 
when he or she is sleeping. 
Music therapy 
                     Research suggests that music therapy can improve sleep quality in acute and 
chronic sleep disorders. Music therapy did improve sleep quality in subjects with acute or 
chronic sleep disorders, however only when tested subjectively. Although these results are 
not fully conclusive and more research should be conducted, it still provides evidence that 
music therapy can be an effective treatment for sleep disorders. 
Lifestyle Changes 
                       Lifestyle adjustments can greatly improve your quality of sleep, especially 
when they’re done along with medical treatments. Incorporating more vegetables and fish 
into your diet, and reducing sugar intake. Limiting your caffeine intake, especially in the 
late afternoon or evening. Decreasing tobacco and alcohol use. Eating smaller low 
carbohydrate meals before bedtime.  
Pharmacological treatment 
                   Several drugs are discovered for the treatment of sleep disorders. Several 
classification of drugs are present on based on their activity and chemical structure. 
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Sedative: 
                 A drug that subdues excitement and calms the subject without inducing, though 
drowsiness may be produced. Sedation refers to the decreased responsiveness to any level 
of stimulation; is associated with some decrease in motor activity and ideation. The subject 
doesn’t loses consciousness in sedation. 
Hypnotics: 
                A drug that induces and/or maintains sleep, similar to normal arousable sleep. 
Hypnotics results in loss of consciousness.  Thus it cannot be confused with “hypnosis”, 
which refers to a trans-like state in which subject becomes highly passive and suggestible. 
           Both of these drugs are used as CNS depressants. Sedative and hypnotic drugs can 
be used for various sleep disorders such as Insomnia, Narcolepsy, Parasomnia, 
Sleepwalking, Night terror, etc,   
Drugs used to treat Sleep Disorders 
 Benzodiazepines- Diazepam, Midazolam, Nitrazepam, Alprazolam, etc.  
 Barbiturates- Phenobarbital, Pentobarbital, Thiopental, Amobarbital, etc. 
 Non benzodiazepines- Zolpidem,  Alpidem, Saripidem, Ocinaplon, , Suproclone, 
etc. 
 Diphenylmethane- Hydroxyzine 
 Azaspirodeconediones- Buspirone , Gepirone, Ipsapirone, Tandospirone, etc. 
 Beta adrenoceptor antagonist- Propranolol. 
 Carbamates- Ethylcamate , Meprobamate , Carisoprodol, Phenprobamate , 
Mebutamate, etc. 
 Beta Carbolines- Abecarnil , Gedocarnil. 
 Dibenzo – bicycle – octadiene - Benzoctamine. 
 MonoAmine Oxidase Inhibitors- Phenelzine. 
 Hormone- Melatonin. 
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Traditional Medicines26-28: 
                  Many plants are traditionally used by natives for diseases before the 
evolution of modern medicinal system. Siddha, Ayurveda, Unani, Homeopathy, 
Tribal medicine, Chinese traditional medicine and many more traditional system 
utilize local flora and fauna to treat various diseases and are effective yet to be 
scientifically proven. Few such medicinal plants are listed below. 
Table. 1 Traditional plants used as Sedative and Hypnotic drugs 
 
    S.No Herbal plants used as 
Sedative and Hypnotic 
1.  Myristrica fragrans 
2.  Anamarita cocculus 
3.  Elettaria cardamomum 
4.  Amomum subulatum 
5.  Aconitum ferox 
6.  Passiflora incarnate 
7.  Lavandula angustifolia 
8.  Valeriana officinalis 
9.  Scoparia dulcis 
10.  Papaver somniferum 
11.  Nepeta cataria 
12.  Rawolfia serpentine 
13.  Withania somnifera 
14.  Cannabis sativa 
15.  Melissa officinalis 
  
 
 
  
PLANT PROFILE 
Plant Profile 
Department of Pharmacognosy, COP, MMC                                                               P a g e  13  
 2. PLANT PROFILE  
PLANT INTRODUCTION 
          Myristica malabarica is commonly called as Malabar nutmeg or kaatuhjathi. It is 
native to India found widely in western  ghats hills. Myristica malabarica seed and seed 
aril is used as spice in Indian foods. They enhance the taste and aromatic flavor of the 
food29. Recent scientific studies proved their biological activity according to their 
traditional claims. They are now known to possess gastroprotective, antipromastigote, 
antioxidant, antifungal, nematicidal, antiproliferative, leukemic and solid tumor.  
COMMON NAME AND TAXONOMY30 
PLANT NAME 
            Myristica malabarica Lam., 
COMMON NAME 
Malabar nutmeg. 
False nutmeg. 
Bombay mace. 
SYNONYMS 
Myristica dactyloides Wall., 
Myristica notha Wall., 
Myristica tomentosa J.Grah., 
Palala malabarica Kuntze., 
VERNACULAR NAMES 
Hindi               : Ramptri, Bambay-jayphal. 
Kannada          : Kanage, Doddajajikai. 
Malayalam      : Ponnampoovu, Kottappannu, Pathiripoovu, Panampalka. 
Plant Profile 
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Sanskrit           : Bandhukapushpa, Gostani. 
Tamil               : Colaivenkai, Kattujatikkai. 
Telugu             : Adavijaikaya, Adividzajikaya. 
TAXONOMICAL STATUS31 
Kingdom          :  Plantae 
Super division  :  Angiosperms 
Phylum             :   Tracheophyta 
 Class                :   Mangoliopsida 
Order                :   Mangoliales 
Family              :   Myristicaceae 
Genus               :   Myristica  
Species             :   Myristica malabarica Lam., 
 
PLANT DESCRIPTION32 
            Myristica malabarica Lam. (Myristicaceae) is a perennial tree about 25m tall. It is 
endemic to India and found widely distributed in Western Ghats forest region. Now it is a 
vulnerable species according to IUCN red list. Hence it must be preserved. 
HABIT AND HABITAT33 
                It is a large 15-25 mts tall perennial tree found evergreen forests upto 800mts. It 
is a swamp and lowland forest habitat tree. Large trunks with greyish black color. 
Flowering and fruiting season starts at feb-aug month. It is vulnerable species listed 
according to ICUN list due to drainage of swamp forests for agricultural purposes 
 
 
Plant Profile 
Department of Pharmacognosy, COP, MMC                                                               P a g e  15  
Morphology 
 Height: 25 m tall. 
 
Fig. 4 Whole Tree of M.M 
 Trunk & Bark: Bark greenish-black, smooth, blaze reddish 
.         
Fig. 5 Trunk and Bark of M.M 
 Branches and branchlets: Branches- horizontal, Branchlets- subtree, 
glabrous. 
 
Fig. 6 Branches of M.M 
Plant Profile 
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 Exaduates: Sap red from cut end of bark, profuse.  
 
Fig. 7 Exudates of M.M 
 Leaves: Leaves simple, alternate, distichous; Petiole 1-1.5cm 
long,caniculate above glabrous, lamina 9.5-22*3.7-10 cm, elliptic or 
elliptic oblong, apex acute or sub-acute, base acuteor attenuate, margin 
entire, glossy above, glabrous and glaucous beneath, coriaceous; mid rib 
raised above. 
 
Fig. 8 Leaves of M.M 
Plant Profile 
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 Inflorescence / Flower: Flowers unisexual, uroceolate, white; male 
flower numerous in number and smaller than female flowers, in auxillary 
cymes; female flowers in umbels, 5-6 flowered. 
 
Fig. 9 Flowers of M.M 
 Fruit and seed: Capsule 5-7.5*1.8-3.5, oblong, pubescent; seed one, Aril 
covering the seed yellow and laciniate. 
 
Fig. 10 Fruit of M.M 
Plant Profile 
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ETHANO MEDICINAL USES34 
               The plant Myristica malabarica is traditionally used as medicine and spices in 
food. The aril is used as febrifuge, cooling, expectorant. In Ayurveda, aril is used for many 
conditions related to vata such as, fever, bronchitis, cough and burning sensation. The fat 
extracted from seed is used to treat indolent ulcers, analgesics and for rheumatism. In 
Ayurveda, for disorders in vata seed fat is used for myalgia, sprains and sores.  The plant 
is also used for anti-inflammatory, Analgesic, anti-ulcer, sedative, hypnotic, and 
antimicrobial actions. 
PHYTOCHEMICAL CONSTITUENTS35 
                The plant Myristica malabarica was found to contain various phytoconstituents 
such as Isoflavones, Diarylnonanoids which consists of Malabaricones A-D, tannins and 
several other phytochemicals are also considered to be present in the plant. A brief study 
of phytoconstituents is needed for this plant. 
Isoflavones 
                  The heartwood of Myristica malabarica is found to have isolation of several 
isoflavones such as 7,4'-dimethoxy-5-hydroxyisoflavone , biochanin a, prunetin and a rare 
alpha-hydroxydihydrochalcone. 
Diarylnanoids 
                 The plant is found to consist of different type of diarylnonanoids which are 
commonly called as Malabaricones. Myristica malabarica contains four Malabaricones A, 
B, C and D. These malabaricones proved pharmacologically for various activity.  
Tannins 
                 From the investigation of the heart wood a tannin 1, 3-diarylpropanol is 
extracted. 
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3. REVIEW OF LITERATURE  
A thorough literature survey was carried out in-order to identify the plant which is 
traditionally used for sedative and hypnotic purpose.  Myristrica malabarica Lam.. was 
selected for the present study because it is traditionally used for sedative and hypnotic 
activity but not yet proven scientifically
36
. 
Literature review of Myristrica malabarica Lam.. was carried out to find out the 
research work on this plant. The review of literature showed that many studies were done 
on different part of this plant. This review is made to confirm that sedative and hypnotic 
activity on the seed aril was not yet proven scientifically. Hence further studies is to be 
carried out. 
 
2.1. PHARMACOGNOSTICAL REVIEW 
 Nagaraju S.K et al., 2013 studied Ecological niche models (ENM) model 
predictions on adaptation of Myristica malabarica Lam., an endemic tree in the 
Western Ghats, India37. 
 R. Indra Iyer G. et al., 2009 studied direct somatic embryogenesis in Myristica 
malabarica Lam.,38 
2.2. PHYTOCHEMICAL REVIEW 
 Bauri A.K et al., 2016 studied crystal structure of an aryl cyclo-hexyl nona-noid. 
Isolated from the spice Myristica malabarica39. 
 Pandey R et al., 2016 studied Rapid screening and quantitative determination of 
bioactive compounds from fruit extracts of Myristica species40. 
 Talukdar AC et al., 2000 studied phytochemical investigation of the heartwood 
of Myristica malabarica and isolated an isoflavone41. 
 Purushothaman KK et al., 1977 studied Malabaricones A--D, novel 
diarylnonanoids isolated from Myristica malabarica., Lam42  
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2.3 PHARMACOLOGICAL REVIEW 
 Pandey R et al., 2016 studied Rapid screening and quantitative determination of in-
vitro antiproliferative activity43. 
 Manna A et al., 2015 studied The variable chemotherapeutic response of Malabaricone-
A in leukemic and solid tumor cell lines depends on the degree of redox imbalance44. 
 Manna A et al .,  2015 studied generation of redox imbalance mediates the cytotoxic 
effect of malabaricone-a in a multidrug resistant cell line45. 
 Patil SB et al., 2011 studied Insulin secretagogue, alpha-glucosidase and antioxidant 
activity of some selected spices in streptozotocin-induced diabetic rats46. 
 B.K. Manjunatha et al., 2011 studied antioxidant and hepato protective effect of 
Myristica malabarica seed aril extracts on carbon tetrachloride induced hepatic 
damage47. 
 Maity .B et al., 2009 studied Regulation of arginase/nitric oxide synthesis axis via 
cytokine balance contributes to the healing action of malabaricone B against 
indomethacin-induced gastric ulceration in mice48. 
 Maity .B et al., 2008 studied Myristica malabarica heals stomach ulceration by 
increasing prostaglandin synthesis and angiogenesis49. 
 Nam Hee Choi et al., 2008 studied Nematicidal activity of malabaricones isolated 
from Myristica malabarica fruit rinds against Bursaphelenchus xylophilus50. 
 Sen R et al., 2007 studied Antipromastigote activity of the malabaricones 
of Myristica malabarica (rampatri)51. 
 Patro BS et al ., 2005 studied Antioxidant activity of Myristica malabarica extracts and 
their constituents52. 
 Rani P et al., 2004 studied Antimicrobial evaluation of some medicinal plants for their 
anti-enteric potential against multi-drug resistant Salmonella typhi54. 
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4. RATIONALE FOR SELECTION 
                Plants are used as food and as well as medicine in our India. Many plants have 
been traditionally used in Siddha and Ayurveda medicinal systems to treat various disease 
and disorders. Although these plants are stated to have medicinal properties but they lack 
in detailed scientific studies. In a desire to bring value and recognition to our traditional 
medicinal system. 
              I have taken this plant Myristica malabarica Lam,. Belonging to the family 
Myristicaceae for the Sedative and Hypnotic studies. This plant is claimed in Ayurveda to 
possess sedative and hypnotic activity and used in formulation as one of the ingredient in 
Vata treatment which is one of the tri dhosha theoy. 
                Only a handful of studies are done in the plant Myristica malabarica. Lack of 
Pharmacognostical, Phytochemical and Pharmacological studies makes this plant an ideal 
target for the scientific studies of traditionally used medicinal plants. This plant is less 
studied and has a great potential in medicinal properties. 
 No pharmacognostical work is done in the seed aril of this plant. 
 No study for Sedative and Hypnotic activity is done in any part of this plant. 
 This plant is claimed to have Sedative and Hypnotic activity in traditional medicinal 
system. 
 Hence, the plant seed aril can be taken for the Sedative and Hypnotic activity 
studies. 
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5. AIM AND OBJECTIVE OF THE STUDY 
5.1 AIM 
 To evaluate Pharmacognostical, Phytochemical, Sedative and Hypnotic activity on 
the seed aril of the plant Myristica malabarica Lam., . 
5.2 OBJECTIVE 
     Pharmacognostical Studies 
 To perform Macroscopical, Microscopical, Qualitative and Quantitative estimation 
of various Physico Phemical constituents of the seed aril. 
  Thus to establish a Pharmacogonostical profile. 
    Phytochemical Studies 
 To perform Preliminary Photochemical Screening of powder and plant extracts. 
 Estimation of various Phytochemical Constituents through analytical method. 
 Isolation of Active Constituents in the seed aril by Column Chromatography. 
 Analysis of the Isolated Constituents by TLC, IR and FTIR spectroscopy. 
 Elucidation of the Isolated Constituents by GC-MS. 
   Pharmacological Studies 
 In-vitro Anti-Oxidant activity is used to determine the presence active constituents 
present in various extracts. 
 In-vivo Spontaneous Locomotor Activity is to be done by Actophotometer for 
Sedative activity. 
 In-vivo Potentiation of Hexobarbital Induced Sleep Time is to be done for Hypnotic 
activity. 
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6. PLAN OF STUDY 
6.1 COLLECTION OF PLANT STUDY 
6.2 AUTHENTICATION OF THE PLANT 
6.3 PHARMACOGNOSTICAL WORK 
 Macroscopical Studies 
 Microscopical Studies 
 Powder microscopy  
 Histochemical study 
 T.S of seed aril 
 Physico chemical constants 
6.4 PHYTOCHEMICAL STUDIES 
 Preparation of extracts 
 Preliminary phytochemical analysis 
 Quantitative estimation of phytoconstituents 
 Fluorescence analysis 
 Thin layer chromatography 
 High performance thin layer chromatography 
6.5 PHARMACOLOGICAL STUDIES 
 In-vitro antioxidant  study 
 DPPH assay 
 H2O2  scavenging assay 
 In-vivo study 
  Spontaneous Locomotor Activity by Actophotometer for 
Sedative activity 
 Potentiation of Hexobarbital Induced Sleep Time for 
Hypnotic activity 
6.6 ISOLATION OF ACTIVE CONSTITUENTS 
 Isolation of active constituents by column chromatography 
 Analysis of Isolate constituents TLC, IR, FTIR and GCMS 
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7. MATERIALS AND METHODS 
PLANT COLLECTION AND AUTHENTICATION 
            Plant was collected from Theni district, Tamil Nadu, authenticated by P. 
Sathiyarajeswaran, Assistant director of Siddha Central Reasearch Institute, Arumbakkam, 
Chennai, as the seed aril of fruit Myristica malabarica Lam., The seed aril were shade 
dried, powdered and was stored in the air tight container and a portion of it is used for the 
Pharmacognostical and Phytochemical studies.   
7.1 PHARMACOGNOSTICAL STUDIES 
          Pharmacognostical study is the preliminary step in the standardization of crude 
drugs. It primarily deals with the identification authentication and standardization of herbal 
medicinal plants through organoleptic character, histological character, powder 
microscopy, quantitative microscopy, histochemical analysis and Physiochemical 
observations as prescribed by an authoritative source such as World Health Organization53-
54. 
            Evaluation of crude drug involves determination of authenticity, quality, purity, 
potency, safety, efficacy, reliability and reproducibility of the evaluation results for varying 
batch of crude drug. This is also used in the detection of nature of adulteration. Systematic 
identification of crude drugs and their quality assurance gives an integral part of drug 
description. 
MACROSCOPICAL EVALVATION 
               Macroscopical character includes organoleptic characters and morphological 
features of the plant were studied. Hence, this observation is of primary importance before 
any further testing can be carried out. Organoleptic characters like color, odor, taste and 
nature are studied. Morphological characters like size, shape, surface, fracture and 
thickness were observed for the determination of safety, efficacy and purity of crude 
drugs55. 
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MICROSCOPIC EVALUATION 
Staining method 
 Fixation of plant organ – The sample or seed was cut fixed in FAA solution 
(Formalin 5ml + Acetic acid 5ml + 90ml of 70% Ethanol). The specimen was dehydrated 
after 24 hours of fixing. The seeds were graded with series of tertiary butyl alcohol, as per 
the standard method56. 
            Infiltration of the specimen - It was carried out by gradual addition of 58 – 60º C 
of melting pointed paraffin wax until Tertiary butyl alcohol (TBA) solution attained super 
saturation. The specimens were cast into paraffin blocks57. 
Sectioning  
 The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10 - 12µg. Dewaxing of the sections were 
done by customary procedures. The sections were stained with Toludine blue. Since 
toludine blue, a polychromatic stain. The staining results were remarkably good. The dye 
rendered pink colour to the cellulose walls, blue to the lignified cells, dark green to subrein, 
violet to mucilage and blue to the protein bodies. Whenever necessary sections were also 
stained with safranin, fast green and iodine for starch58.  
PHOTO MICROGRAPHS 
 Microscopic descriptions of tissues were supplemented with photo micrographs 
whenever necessary. Photographs of different magnifications were taken with Nikon lab 
photo 2 microscopic units. For normal observations bright field was used. 
  For the study of crystals and lignified cells, polarized light was employed. Since, 
these structures have birefringent property under polarized light they appear bright against 
dark background. Descriptive terms of the anatomical features are as given in the standard 
anatomy books. 
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POWDER MICROSCOPY59 
              The shade dried, powdered plant material was used for powder microscopic 
analysis. The organoleptic characters were observed and to identify the different 
characteristic features various staining reagent were used. Powder was stained with 1% 
phloroglucinol in 90% ethanol, concentrated hydrochloric acid and observed through 
microscope. All the lignified cells stained with pink color. Calcium oxalate crystals were 
observed under the polarized light microscope.   
HISTOCHEMICAL STUDIES60 
            Portions of seed aril of the plant Myristica malabarica were used. The peels were 
soaked in water before taking the sections. The sections were stained using specific 
reagents (N/50 iodine, dilute ferric chloride, phloroglucinol and con.hydrochloric acid, 
picric acid, ortho toludine blue and dragendroff reagent) to observe and locate starch, 
lignin, tannin, protein, flavonoid and alkaloid respectively as per the protocols. The stained 
sections were then washed in water to remove the excess stain and observed under a 
microscope(Olympus BX41).Pictures of the sections were taken by DP71 fixed with 
Olympus BX41microscope and processed by using the software image pro express 6.0. 
PHYSICO-CHEMICAL CONSTANTS61-63 
             Shade dried powdered plant materials of the fruits of Myristica malabarica was 
used for the determination of the Physiochemical constants in accordance with the WHO 
guidelines. 
DETRMINATION OF ASH VALUES 
 Ash values are helpful in determining the quality and purity of a crude drug in the 
powdered form. The residue remaining after incarnation is the ash content of the drug, 
which simply represents inorganic salts, naturally occurring drug or adhering to it or 
deliberately added to it, as a form of adulteration. 
 Ash value of a crude drug is defined as the inorganic residue remaining after 
incineration, which complies of inorganic salts, naturally occurring in drug or adhering to 
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it or deliberately added to it as a form of adulteration. Hence it is used for the determination 
of the quality and purity of the crude drug in the powdered form.  
TOTAL ASH: 
 Total ash method is designed to measure the total amount of material remaining 
after ignition.  They include both physiological ash which is derived from plant tissue itself 
and non-physiological ash which is the residue of extraneous matter adhering to the plant 
surface. 
Procedure:  
 Silica crucible was heated to red hot for 30 minutes and cooled in the desiccators 
Incinerate about 2 to 3 g accurately weighed, of the ground drug in a tarred silica dish at a 
temperature not exceeding 4500c until the sample is free from carbon, cooled in desiccators 
and weighed. The ash obtained was weighed. The percentage of total ash was calculated.  
             %Total Ash value= (Wt of total ash/ wt of total drug taken) x 100                          
WATER SOLUBLE ASH: 
The difference in weight between the total ash and the residue after treatment of the total 
ash in water.  
Procedure: 
 Total ash obtained is boiled for 5 minutes with 25 ml of water, insoluble matter 
were collected in an ash less filter paper, washed with hot water and ignite for 15 min at a 
temperature not exceeding 4500.  Subtract the weight of this residue in mg from the weight 
of total ash. Calculate the content of water-soluble ash in mg per gram of air-dried material.  
         %Water soluble ash = (Weight of residue obtained/ Weight of the sample taken) X 
100  
ACID INSOLUBLE ASH: 
 The residue obtained after boiling the total ash with dilute hydrochloric acid, the 
remaining insoluble matters are ignited and measured. This measures the amount of silica 
present, especially as sand and siliceous earth.  
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Procedure:  
 To the crucible containing total ash of the sample, 25 ml of dilute hydrochloric acid 
is added. The insoluble matter is collected on an ash less filter paper (Whatman 41) and 
washed with hot water until the filtrate is neutral.  Filter paper containing the insoluble 
matter to the original crucible, dry on hot plate and ignite to constant weight. Allow the 
residue to cool in a suitable desiccators for 30 minutes and weighed without delay. Content 
of acid-insoluble ash with reference to the air dried drug is calculated. 
    %Acid insoluble ash = (Weight of the residue obtained/ Weight of the sample taken) X 
100 
SULPHATED ASH 
 Sulphated ash test is used to measure the amount of residual substance not 
volatilized from a sample. These test are usually used to determine the content of inorganic 
substance.  
Procedure:  
 Silica crucible are heated to redness for 10 minutes, allowed to cool in a desiccator 
and weigh. 2 g of sample were accurately weighed, ignited gently then thoroughly charred. 
Cool, moistened the residue with 1 ml of sulphuric acid, heat gently until the white fumes 
are no longer evolved and ignite at 800 ± 25o until all black particles have disappeared. 
Crucible are allowed to cool, add few drops of sulphuric acid and heat. Ignite as before, 
allow to cool and weigh. This process is repeated until two successive weighing differ by 
more than 0.5 mg.  
 %Sulphated ash = (weight of the residue obtained/ Weight of the sample taken) X 
100 
DETERMINATION OF EXTRACTIVE VALUES: 
 Extractive values are useful for the evaluation of Phytoconstituents especially when 
the constituents of a drug cannot be readily estimated by any other means. Further these 
values indicate the nature of the active constituents present in a crude drug. 
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Determination of water soluble extractive 
                     5gm of air dried coarsely powdered sample was weighed and macerated with 
100ml of chloroform water (95ml distilled water and 5ml chloroform) in a closed flask for 
24 hours. It was shaken frequently for six hours and allowed to stand for rest eighteen 
hours. It was then filtered rapidly, taking precautions against loss of solvent and 25ml of 
the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish and was dried 
at 105°C for 1 hour in the hot air oven and cooled in desiccators for 30min and weighed. 
The process was repeated till a constant weight was obtained; the percentage of water 
soluble extractive value was calculated with reference to the air dried drug. 
    %Water soluble extractive value = (wt of the dried extract/ wt of the sample taken) X 
100 
Determination of alcohol soluble extractive 
                5gm of the coarsely powdered sample was weighed and macerated with 100ml 
90% ethanol in a closed flask for 24 hours. It was shaken frequently for six hours and 
allowed to stand for eighteen hours. It was then filtered rapidly, taking precautions against 
loss of solvent and 25ml of the filtrate was evaporated to dryness in a tarred flat bottomed 
shallow dish. It was dried at 105°C for 1hour in a hot air oven. The dish was cooled in 
desiccator and weighed. The process was repeated till the constant weight was obtained. 
The percentage of alcohol soluble extractive value with reference to the air dried drug was 
calculated. 
     % Alcohol soluble extractive = (wt of the dried extract/ wt of the sample taken) X 100 
Determination of non-volatile ether soluble extractive (fixed oil content) 
                     A suitably weighed quantity of the sample was transferred to an extraction 
thimble and extracted with solvent ether or petroleum ether (Boiling Point 40 - 60°C) in a 
Soxhlet for 6 hours. The extract was filtered into a tarred evaporating dish, evaporated and 
dried at 105°C to constant weight. The percentage of nonvolatile ether soluble extractive 
value with reference to the air dried drug was calculated.  
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 %Nonvolatile ether soluble extractive= (wt of the dried extract/ wt of the sample) 
X 100 
Determination of volatile ether soluble extractive 
                     2gm of powdered sample was accurately weighed and extracted with 
anhydrous diethyl ether in a continuous extractive apparatus for 20hours. The ether solution 
was transferred to tarred porcelain dish and evaporated spontaneously, dried over 
phosphorous pent oxide for 18hours and the total ether extract was weighed. The extract 
was heated gradually and dried at 105°C to constant weight. The loss in weight represents 
the volatile portion of the extract. 
 Volatile ether soluble extractive= (wt of the dried extract/ wt of the sample taken) 
X 100 
DETERMINATION OF MOISTURE CONTENT: 
Loss on drying 
                   10 g of the sample substances (without preliminary drying) was taken in a 
tarred evaporating dish.  Use of high speed mill in preparing the samples are avoided. The 
sample in the tarred evaporating dish were placed in the drying chamber (105°C) for 5 
hours and weigh. Drying and weighing is continued every one hour interval until the 
difference between the two successive weights is not more than 0.25 percent. Constant 
weight is reached when the two consecutive weighing after drying for 30 minutes and 
cooling for 30 minutes in a desiccators, show not more than 0.001 g difference. Percentage 
moisture content is compared with respect to the air dried sample. 
 % Moisture content = (Final weight of the sample/ Initial weight of the sample) X 
100 
Determination of foaming index 
                    1gm of the coarsely powdered drug was weighed and transferred to 500ml 
conical flask containing 100ml boiling water. The flask was maintained at temperature 80-
90°C for about 30min. It was then cooled and filtered into a volumetric flask and sufficient 
water was added through the filtrate to make up the volume to 100ml. The decoction was 
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poured into 10 stopper test tube (height 16cm, diameter 16mm) in successive portions of 
1ml, 2ml, 3ml, 4ml up to 10ml and the volume of the liquid in each tube was adjusted with 
water to 10ml. The tubes were stoppered and shaken in a length wise motion for 15 seconds, 
two shakes per second. Allowed to stand for 15min and the height of the foam was 
measured. The results are assessed as follows. 
                    If the height of the foam in every tube is less than 1cm, the foaming index is 
less than   100. If a height of 1cm is measured in any tube, the volume of the plant material 
decoction in the tube (a) is used to determine the index. If this tube is the first or second 
tube in a series, prepare an intermediate dilution in a similar manner to obtain a more 
precise result. 
                    If the height of the foam is more than 1cm in every tube, the foaming index is 
over 1000. In this case repeat the determination using a new series of dilution of the 
decoction in order to obtain a result. Calculate the foaming index using the following 
formula: 
                                      Foaming index = 1000/a 
     Where, a = the volume in ml of the decoction used for preparing the dilution in the tube 
where foaming to a height of 1cm is observed. 
Determination of swelling index  
                  The swelling index is the volume in ml occupied by the swelling of 1gm of 
plant material under specified conditions. A specified quantity of the plant material were 
previously reduced to the required fineness was accurately weighed and transferred into a 
25ml glass stoppered measuring cylinder. The internal diameter of the cylinder should be 
about 16mm, the length of the graduated portion about 125mm, marked in 0.2ml divisions 
from 0 to 25ml in an upward direction. Unless otherwise indicated in the test procedure, 
add 25ml of water and shake the mixture thoroughly every 10min for 1hour, allowed to 
stand for 3 hours at room temperature. The volume in ml occupied by the plant material 
was measured including any sticky mucilage. Calculate the mean value of the individual 
determination, related to 1gm of plant material. 
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DETERMINATION OF VOLATILE OIL IN THE DRUG: 
 Determination of the volatile oil in a sample is done by distilling the drug with a 
mixture of water and glycerine, collecting the distillate in a graduated tube in which the 
aqueous portion is automatically separated and returned to the flask and the volume of oil 
collected is measured.  
 The content of the oil is expressed as percentage v/w. and it is performed in the 
clevenger’s apparatus.  
Procedure:  
 Weighed amount of sample is distilled with the 75 ml of glycerine and 175 ml of 
water in the one liter distilling flask with few pieces of earthen ware and one filter paper 
15 cm cut into small head. Condenser is placed above the flask and water is allowed to run 
through the condenser. Heating is discontinued after 3 to 4 hours. Volume of oil collected 
is read in the graduated tube. The measured yield of volatile oil is taken to be the content 
of volatile oil in the drug. 
Percentage of volatile content = (Amount of volatile oil obtained/ Weight of drug)   X 100 
QUALITATIVE AND QUANTITATIVE ESTIMATION OF HEAVY METALS 
AND INORGANIC ELEMENTS64 
                         Plant minerals play a vital role in metabolism. Presence of elements vary 
with the soil, climate conditions etc. There are essential and non-essential elements which 
may be beneficial or harmful to living things. Non-essential elements like lead, arsenic, 
cyanide, chromium, cadmium, aluminium and silver bring about toxic effects resulting in 
intoxication. Hence, qualitative and quantitative estimation of inorganic elements in the 
plant Myristrica malabarica Lam., were carried out. 
QUALITATIVE ANALYSIS OF INORGANIC ELEMENTS AND HEAVY 
METALS  
                        To the ash of the drug material 50%v/v hydrochloric acid was added and 
kept for 1 hour. It was filtered and the filtrate was used for the following tests. 
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➢ Aluminium: White gelatinous precipitate of aluminium hydroxide is formed on 
addition of ammonia solution. It is slightly soluble in excess of the reagent. The 
precipitate dissolves readily in strong acid and base, but after boiling it becomes 
insoluble.   
➢ Arsenic:  Arsenious salts in neutral solution react with solution of copper sulphate 
to form green precipitate (scheele’s green) which on boiling gives a red precipitate 
of cupric oxide. 
➢ Borate: The mixture obtained by the addition of sulpuric acid and alcohol (95%) 
to a borate when ignited, burns with flame tinged with green. 
➢ Calcium: Solution of calcium salts, when treated with ammonium carbonate 
solution, yield a white precipitate after boiling and cooling the mixture (it is 
insoluble in ammonium-chloride solution). 
➢ Carbonate: Carbonate, when treated with dilute acid effervescence, liberating 
carbon-dioxide which is colourless and produces a white precipitate in calcium 
hydroxide solution. 
➢ Chlorides: Chlorides, when treated with silver nitrate solution, yield a white crude 
precipitate which is insoluble in nitric acid, but soluble after being well washed 
with water, in diluted ammonia, from which it is re precipitated by the addition of 
nitric acid. 
➢ Copper: An excess of ammonia, added to a solution of a cupric salt, produces first 
a bluish precipitate and then a deep blue coloured solution. 
➢ Iron: Solution of ferric salts, when treated with potassium ferrocyanide solution, 
yields an intense blue precipitate which is insoluble in dilute HCl. 
➢ Lead: Strong solution of lead salts, when treated with HCL, yield a white 
precipitate. Which is soluble in boiling water and is re deposited as crystals when 
the solution is cooled. 
➢ Magnesium: Solution of magnesium salts, when treated with ammonium carbonate 
solution and boiled, yield a white precipitate, but yield no precipitate in the presence 
of ammonium chloride solution. 
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➢ Mercury: Solution of mercury salts, when treated with sodium hydroxide solution, 
yields a yellow precipitate. 
➢ Nitrate: With solution of ferrous sulphate no brown colour was observed but if 
sulphuric acid is added (slow from the side of the test tube), a brown colour is 
produced at the junction of two liquids, indicating the presence of nitrates. 
➢ Phosphate: Solution of phosphate when treated with silver nitrate with dilute 
ammonia solution and in dilute nitric acid yield yellow precipitate of normal silver 
ortho phosphate (distinction from meta and pyrophosphate) solution. 
➢ Potassium: Moderately strong potassium salts, which have been previously ignited 
to remove ammonium salts, when treated with perchloric acid (60%) yield a white 
crystalline precipitate. 
➢ Silver: Solution of silver salts, when treated with potassium iodide solution yield a 
cream coloured precipitate which is insoluble in dilute ammonia solution and in 
nitric acid. 
➢ Sulphates: Solution of sulphates, when treated with lead acetate solution yields a 
white precipitate which is insoluble in ammonium acetate solution and in sodium 
hydroxide. 
QUANTITATIVE ESTIMATION OF INORGANIC ELEMENTS65 
Inductive coupled plasma-Optical emission spectroscopy (ICP-OES)  
         It is an excellent multi-element technique with relatively good sensitivity and 
selectivity when configured correctly. This technique utilizes the plasma as an ion source 
or light emission source are capable of producing values. 
 
QUANTITATIVE ANALYSIS OF HEAVY METALS 
Instrumentation parameters:  
Instrument name: Inductive coupled plasma-Optical emission spectroscopy 
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Instrument Model: PE Optima 5300DV ICP-OES; Optical system Dual view-axial or 
radial 
Detector system: Charge coupled detector, (UV-Visible detector which is maintaining at 
-40º C) to detect the intensity of the emission line. 
Light source (Torch): Positioned horizontally in the sample compartment along the 
central axis of the spectrometer optics. Changing from axial to radial viewing is a simple 
software command and is accomplished by computer control of a mirror located in the 
optical path. The torch assembly of this system comprises of two concentric quartz tubes. 
Standard alumina injector: 2.0mm inner diameter.  
Spray chamber: Scott type 
Nebulizer: Cross flow gem tip. 
Preparation of sample by acid digestion method: 
   50mg of powder was treated with acid mixture of sulphuric acid: water in the ratio 
of 4:1in the Kjeldahl flask and heated continuously till the solution is colorless. The sample 
mixture was then transferred in a 25ml volumetric flask and made up to the volume with 
distilled water. Blank solution was prepared as above without sample. 
            The standards of Arsenic, Lead, Mercury and Cadmium were prepared as per the 
protocol and the calibration curve was developed for each of them. 
Detection: 
            Samples were analyzed for the detection and quantification of the calcium, 
sulphate, borate, silver, aluminum, copper, potassium, chloride by Inductively Coupled 
Plasma Emission Spectrometry. 
7.2 PHYTOCHEMICAL STUDIES 
PRILIMNARY PHYTOCHEMICAL SCREENING66-68 
            Phytochemical evaluation is used to determine the nature of Phytoconstituents 
present in the plant by using suitable chemical tests. It is essential to study the 
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pharmacological activities of the plant. It can be done by confirmation with different 
chromatographic techniques like TLC and HPTLC. Therefore a complete investigation is 
required to characterize the Phytoconstituents qualitatively and quantitatively. 
Preparation of Extracts  
            Extraction is the preliminary step involved in the phytochemical studies. It brings 
out the metabolites into the extracting solvent depends upon its polarity. 
Extraction 
             The first step was the preparation of successive solvent extracts. The dried coarsely 
powdered sample of Myristica malabarica (500gm) was first extracted with Benzene (60-
80°C) in Soxhlet apparatus and then with solvents of increasing polarity like ethanol at (60 
- 70ºC). They were then followed with distillation by Clevenger’s appartus. Each extract 
was concentrated using rotary vacuum evaporator. The percentage yield, colour and 
consistency of these extracts were recorded and preceded for further detailed 
Phytochemical and pharmacological screening. 
PRELIMINARY PHYTOCHEMICAL SCREENING  
                 The chemical tests for various Phytoconstituents in the dried powder and 
extracts of Myristica malabarica Lam., were carried out as described below and the results 
were recorded. 
1. Detection of Alkaloids  
➢ Dragendorff’s reagent : 
             The substance was dissolved in 5ml of distilled water, to this 5ml of 2M 
HCL was added until an acid reactions occurs, then 1ml of Dragendorff’s reagent 
was added and examined for an immediate formation of an orange red precipitate. 
 
➢ Mayer’s reagent: 
           The substance was mixed with little amount of dilute hydrochloric acid and 
Mayer’s reagent and examined for the formation of white precipitate. 
 
                                                                                                                                            Materials and Methods 
 
Department of Pharmacognosy, COP, MMC                                                             37 | P a g e  
➢ Wagner’s reagent : 
            The test solution was mixed with Wagner’s reagent and examined for the 
formation of reddish brown precipitate. 
2. Detection of Glycosides  
➢ Borntrager’s test : 
             The powdered material was boiled with 1ml of sulphuric acid in a test tube 
for five minutes. Filtered while hot, cooled and shaken with equal volume of 
chloroform. The lower layer of solvent was separated and shaken with half of its 
volume of dilute ammonia. A rose pink to red colour is produced in the ammonical 
layer. 
➢ Modified Borntrager’s test : 
            The test material was boiled with 2ml of the dilute sulphuric acid. This was 
treated with 2ml of 5% aqueous ferric chloride solution (freshly prepared) for 5 
minutes, and shaken with equal volume of chloroform. The lower layer of solvent 
was separated and shaken with half of its volume of dilute ammonia. A rose pink 
to red colour is produced in the ammonical layer.  
 3. Detection of Steroids and Triterpenoids 
➢ Libermann Burchards Test: 
            The powdered drug was treated with few drops of acetic anhydride, boiled 
and cooled. Conc.sulphuric acid was added from the sides of the test tube, brown 
ring is formed at the junction of two layers and upper layer turns green which shows 
presence of steroids and formation of deep red color indicates presence of tri 
terpenoids. 
➢ Salkowski Test : 
          The extract was treated with few drops of concentrated sulphuric acid, red 
color at lower layer indicates presence of steroids and formation of yellow colored 
lower layer indicates presence of tri terpenoids 
. 
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 4.  Detection of Flavonoids  
➢ Shinoda test : 
           To the solution of extract,  few piece of magnesium turnings and 
concentrated Hcl was added drop wise, pink to crimson red, occasionally green to 
blue color appears after few minutes indicates the presence of flavonoids. 
➢ Alkaline reagent test : 
           To the test solution few drops of sodium hydroxide solution was added, 
intense yellow color is formed which turns to colorless on addition of few drops of 
dilute acid indicate presence of flavonoids. 
 5. Detection of Carbohydrates 
➢ Molisch’s test : 
              To the test solution few drops of alcoholic alpha napthol and few drops of 
conc. sulphuric acid were added through the sides of test tube, purple to violet color 
ring appears at junction. 
➢ Fehling’s test : 
              The test solution was mixed with Fehling’s I and II and heated and 
examined for the appearance of red coloration for the presence of sugar. 
  6. Detection of Phenols  
➢ Ferric chloride test : 
               A small quantity of substance were dissolved with 2ml distilled water and 
a few drops of 10% aqueous ferric chloride solution was added and observed for 
appearance of blue or green color. 
  7. Detection of Proteins  
➢ Biuret test : 
The sample was treated with 5-8 drops of 10% w/w copper sulphate 
solution, violet color is formed. 
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8. Detection of Tannins 
➢ Lead acetate test : 
                The test solution was mixed with basic lead acetate solution and 
examined for formation of a white precipitate. 
➢ Ferric chloride test : 
                A few drops of 5% aqueous ferric chloride solution was added to 2ml of 
an aqueous extract of the drug and examined for the appearance of bluish black 
color. 
  9. Detection of Saponins  
➢ A drop of sodium bicarbonate solution was added to the sample and the mixture 
was shaken vigorously and left for 3 minutes. Development of any honey comb 
like froth was examined. 
   10. Detection of Gum and Mucilage 
➢ Small quantities of test substances was dissolved in 5 to 10ml of acetic 
anhydride by means of heat, cooled and add 0.05ml of concentrated sulphuric 
acid; it is examined for the formation of bright purplish red color. 
    11. Detection of fixed oils and fats: 
➢ Small quantities of extracts were pressed between two filter papers. An oily 
stain on filter paper indicates the presence of fixed oils and fats. 
 
FLUORESCENT ANALYSIS69 
                   Fluorescence analysis was carried out in day light and in UV light. The leaf 
powder and extracts were treated with different solvents and the fluorescence was observed 
in day light and in near and far UV light.    
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QUANTITATIVE ESTIMATION OF TOTAL PHENOLIC AND TOTAL 
FLAVONOID CONTENT70-74 
Total Flavanoid content 
                Total flavanoid content was determined by calorimetric method, using quercetin 
as a standard. The test samples were individually dissolved in DMSO. Then the sample 
solution (150 µl) was mixed with 150 µl of 2% aluminium chloride. After 10min of 
incubation at ambient temperature, the absorbance of the supernatant was measured at 
435nm using spectrophotometer. Three replicates were made for each test sample. The total 
flavanoid content was expressed as quercetin equivalent in mg/gm extract (mg QRT/gm 
extract). 
Total phenolic content (Folin – Ciocalteu’s assay) 
                 Total phenolic content of the extracts were determined using Folin –Ciocalteu’s 
assay. 0.5ml extract solutions were mixed with 2.5ml of 10 fold diluted Folin Ciocalteu’s 
reagent and 2.5ml of 7.5% sodium carbonate. After incubation at 40°c for 30 minutes, the 
absorbance of the reaction mixtures was measured at 765nm in a spectrophotometer. Three 
replicates were made for each test sample. Gallic acid was used as a standard and total 
phenolic content of the extract was expressed in mg of Gallic acid equivalents (mg GAE/g 
extract).  
Total alkaloid content 
                Accurately measure Aliquots (.2, .4, .6, .8, 1.0 ml) atropine standard solution and 
transferred in to volumentric flask. To the standard 5ml of phosphate buffer and 5 ml of 
BCG solution were added. To the mixture 1, 2, 3, 4 and 5 ml of chloroform was added. 
The extracts were dissolved in chloroform and diluted accordingly. The solutions were 
viewed at 470 nm with chloroform as blank. Atropine sulphate is used as a standard and 
total alkaloid content was expressed in mg of atropine sulphate equivalents (mg 
AS/gmextract) 
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CHROMATOGRAPHY75-77 
               Chromatography methods are important analytical tool in the separation,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
identification and estimation of components present in the plant. 
 
THIN LAYER CHROMATOGRAPHY 
Principle 
              Thin layer chromatography is a technique used for the separation, identification 
and estimation of single or mixture of components present in the various extracts. It is 
reliable technique in which solute undergoes distribution between two phases, stationary 
and mobile phase. The separation is mainly based on the differential migration that occurs 
when a solvent flows along the thin layer of stationary phase. This may be achieved by 
partition and adsorption depending on stationary phase used. 
TLC Plate Preparation 
              The plates were prepared using Stahl TLC spreader. 40gm of silica gel G was 
mixed with 85ml of water to prepare homogenous suspension and poured in the spreader. 
0.25mm thickness of plates was prepared, air dried until the transparency of the layer 
disappeared, then dried at 110°C for 30 minutes and kept in desiccators. 
Selection of mobile phase:   
            Solvent mixture was selected on the basis of the Phytoconstituents present in each 
extract. Factors such as nature of components, stationary phase, mobile phase, polarity, 
influence the rate of separation of constituents. From the vast analysis, best solvent was 
selected which showed good separation with maximum number of components.   
HPTLC- FINGERPRINT PROFILE: 
           HPTLC is one of the versatile chromatographic method which helps in the 
identification of compounds and thereby authentication of purity of herbal drugs. The time 
required in this method for the demonstration of most of the characteristic constituents of 
a drug is very quick and short. In addition to qualitative detection, HPTLC also provides 
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semi-quantitative information on major active constituents of a drug, thus enabling an 
assessment of drug quality.   
           HPTLC serves as a convenient tool for finding the distribution pattern of 
Phytoconstituents which is unique to each plant. The fingerprint obtained is suitable for 
monitoring the identity and purity of drugs and for detecting adulteration and substitution. 
HPTLC technique is helpful in order to check the identity, purity and standardize the 
quantity of active principles present in the herbal extract. 
Instrument Conditions: 
Sample used               : Ethanol Extract 
Instrument  : CAMAG HPTLC 
HPTLC Applicator : CAMAG LINOMAT IV 
HPTLC Scanner : CAMAG TLC SCANNER II 
Sample dilution : 100mg of sample extracted with 1ml of Ethyl acetate 
Volume of injection : 20µl 
Mobile phase  : Hexane: Ethyl acetate: Chloroform: Toluene: Methanol: Formic 
 Acid (2:2:1:4:0.5: 0.5) 
Lambda max  : 254nm 
Lamp   : Deuterium 
Stationary phase       : TLC silica gel 60 F254 (Merck) 
Equipment: 
          A Camag HPTLC system equipped with a sample applicator Linomat IV, Twin 
trough plate development chamber, TLC Scanner II. 
Chromatographic conditions: 
           The estimation has been done using the following chromatographic conditions. 
Chromatography was performed on a 10 × 10cm pre-activated HPTLC silicagel 60 F254 
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plate. Samples were applied to the plate as 6mm wide band with an automatic TLC 
applicator Linomat IV with nitrogen flow (CAMAG, Switzerland), 8mm from the bottom. 
Densitometric scanning was performed on CAMAG scanner II. The plates were pre-
washed with solvent ethyl acetate. 
 
7.3 PHARMACOLOGICAL STUDIES 
7.3.1IN VITRO ANTI OXIDANT ACTIVITY78-80 
               There has been a lot of interest in the development of alternative medicine for 
sleep disorders. Oxidative stress plays a major role in the progression of sleep disorder. It 
occurs when the balances between free radicals which inhibits GABA binding activity and 
anti-oxidants helps in prevention of GABA binding inhibition. 
 Anti-oxidants like poly phenols and flavonoids are therefore very helpful in 
reduction of stress factors and free radical formation which inhibits GABA binding 
activity. It has become evident that flavonoids are able to exert enhancement of GABA 
binding activity even at low concentration81-82. 
          In vitro antioxidant activities for the extracts were carried out using the following 
methods. 
                              1. DPPH assay 
                              2. Hydrogen peroxide scavenging assay. 
DPPH Assay:  1, 2-DIPHENYL-2-PICRYL HYDRAZYL RADICAL (DPPH) 
Initial volume 0.1 mL of various concentrations of samples was mixed with 0.4 mL 
of 0.3M DPPH reagent prepared in ethanol. The mixture was shaken thoroughly and 
incubated in the darkness at room temperature for 30 min. The absorbance of the reaction 
was measured spectrophotometrically at 517nm, immediately after mixing and then after 
incubation as well. The scavenging effect of DPPH free radical was calculated by using the 
following equation. 
% scavenging activity = Abs (control) - Abs (standard) / Abs (control) × 100  
                                                                                                                                            Materials and Methods 
 
Department of Pharmacognosy, COP, MMC                                                             44 | P a g e  
Where control is the absorbance of the blank (a reaction with all the reagents except the 
test extract), and absorbance of sample is the absorbance of the test extract. Tests were 
carried out in triplicates to obtain 50% inhibition (IC50). Using Butylated hydroxy 
Toulene. 
 
HYDROGEN PEROXIDE SCAVENGING ASSAY (HPSA) 
                  The ability of the extracts to scavenge hydrogen peroxide was determined 
according to the method of Ruch. A solution of Hydrogen peroxide (2mmol/l\lt) was 
prepared in phosphate buffer (PH 7.4). Various concentrations of extracts (10-100µg/ml) 
were added to hydrogen peroxide solution (0.6ml).  Absorbance at 230nm was determined 
after 10min against a blank solution containing phosphate buffer without hydrogen 
peroxide. 
% scavenging activity = Abs (control) - Abs (standard) / Abs (control) × 100 
Compared with the ascorbic acid standard. 
 
7.3.2 IN-VIVO EVALUVATION SEDATIVE AND HYPNOTIC ACTIVITY 
EXPERIMENTAL DESIGN:  
Materials and Methods 
Plant extract 
             Benzene, ethanol and aqueous extracts from seed aril of Myristica malabarica 
Lam., 
Animal selection and procurement83 
               Healthy young Swiss-Albino mice (weighing about 20-30gm) were procured 
from the Madras Medical College animal house. The animals used for the entire study was 
approved by the Institutional Animal Ethical Committee which is certified by the 
Committee for the purpose of control and supervision of experiments on animals, India. 
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Approved CPCSEA Registration No: IAEC/MMC/10/2016                 Dated: 21/11/2016            
                   The procured animals were kept in a clean, dry polycarbonate cages and 
maintained in a well-ventilated animal house. The temperature of experimental animal 
room was maintained at 22ºC (± 3ºC) and the relative humidity was maintained from 50-
60%. Lighting was artificially maintained for 12hrs dark and 12hrs light. All the animals 
were kept in the cages for at least 5days prior to dosing for acclimatization to the laboratory 
conditions. The animals were fed with standard pellet diet and water was given ad libitum. 
Before starting the dose, the animals were fasted overnight but allowed to access water. 
 
 
ACUTE TOXICITY STUDIES84-85 
ACUTE ORAL TOXICITY STUDY (FIXED DOSE PROCEDURE) OECD 425 
GUIDLINE FOR THE TESTING OF CHEMICALS 
 The organization of economic co – operation and development (OECD) guideline 
425 was followed the acute oral toxic fixed dose method is a stepwise procedure with 5 
rats of single sex per step (one animal per step). Depending upon the mortality and 
morbidity status of the animal, on average of 2 to 4 steps may be necessary to allow 
judgment on the acute oral toxicity of the substance. This procedure results in the use of 
minimal number of animal while allowing for acceptable data based scientific conclusion.  
                Literature survey showed that acute toxicity of the extracts was determined 
according to the OECD guideline No. 425 (20).  Swiss albino mice of both sex weighing 
27-30 g were used for Pet ether and Ethanolic Extract of Myristica malabarica Lam.,  was 
given to four groups (n = 5) of animals each at 5, 50, 300 and 2000 mg kg-1 b.w. p. o. The 
treated animals were under observation for 14 days, for mortality and general behaviour. 
No death was observed till the end of the study. The test sample was found to be safe up to 
the dose of 2000 mg/kg.  So, 1/5th (400mg) of the dose were selected for this study.  
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SEDATIVE ACTIVITY86-88 
Evaluvation of Sedative Activity by Spontaneous Locomotor Activity Using 
Actophotometer. 
Grouping of animals 
                Animals were divided into 5 groups of six animals each. 
 Group I:  Vehicle -2% tween 80 solution (2ml/kg b.wt) was orally 
administered. 
 Group II: Standard drug [Diazepam] - (3 mg/kg b.wt) was orally 
administered. 
 Group III: Test drug I [Benzene extract] - (400mg/kg) was orally 
administered. 
 Group IV: Test drug II [Ethanolic extract] - (400mg/kg b.wt) was orally 
administered. 
 Group V: Test drug III [Aqueous extract] - (400mg/kg b.wt) was orally 
administered. 
After 30 mins of oral administration of drugs the animals were experimented for sedative 
activity using Actophotometer, 
ACTOPHOTOMETER 
                   It consists of six built in photo sensor and 4 digit digital counter to indicate the 
loco meter activity. It measures then spontaneous and indicated activity with digital 
totalize. It also incorporates electric shock of up to 100 volts for activating rats. The 
stimulus is variable from 0 to 100v & indicating on meter 
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Fig. 11 Actophotometer 
                Most of the CNS acting drugs influence the locomotor activities in man & 
animals. The CNS depressant drugs such as barbiturates & alcohol reduce the motor 
activity while the stimulants such as caffeine & amphetamines increase the activity. In 
other words, the locomotor activity can be an index of wakefulness (alertness) of mental 
activity. 
The locomotor activity (horizontal activity) can be easily measured using an 
actophotometer which operates on photoelectric cells which are connected in circuit with 
a counter. When the beam of light falling on the photo cell is cut off by the animal, a count 
is recorded. An actophotometer could have either circular or square arena in which the 
animal moves. Both rats & mice may be used for testing in this equipment. 
 
HYPNOTIC ACTIVITY89-92 
Evaluvation Of Hypnotic Activity By Potentiation Of Hexobarbital Induced Sleep 
Time. 
Grouping of animals 
                  Same group of animal is use for this experiment after washout period of 15 days 
for the given test drug to be completely excreted. 
                 Animals were divided into 5 groups of six animals each. 
o Group I:  Vehicle -2% tween 80 solution (2ml/kg b.wt) was orally 
administered. 
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o Group II: Standard drug [Diazepam] - (3 mg/kg b.wt) was orally 
administered. 
o Group III: Test drug I [Benzene extract] - (400mg/kg) was orally 
administered. 
o Group IV: Test drug II [Ethanolic extract] - (400mg/kg b.wt) was orally 
administered. 
o Group V: Test drug III [Aqueous extract] - (400mg/kg b.wt) was orally 
administered. 
 
Fig. 12 : Righting reflex  
All groups of animals will be administered with Hexobarbital 50mg/kg, i.p. after 1 hour of 
standard and test drug administration.  
Writhing reflex is an indicator of mice wakefulness or conscious. This parameter is 
evaluvated for this activity and the extension of sleep time caused by the drug is noted and 
reported for hypnotic activity. 
Potentiation of hexobarbital sleeping time 
                 Thirty min after i.p. or s.c. injection or 60 min after oral dosing 60 mg/kg 
hexobarbital is injected intravenously. The animals are placed on their backs on a warmed 
(37oC) pad and the duration of loss of the righting reflex (starting at the time of 
hexobarbital injection) is measured until they regain their righting reflexes. Injection of 60 
mg/kg hexobarbital usually causes anesthesia for about 15 min. If there is any doubt as to 
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the reappearance of the righting reflex, the subject is placed gently on its back again and, 
if it rights itself within one minute, this time is considered as the endpoint. The test and 
standard drugs are given prior 1hr orally before i.p administration of hexobarbital. The 
extension of time taken for righting reflex is noted for various drugs.  
STATISTICAL ANALYSIS93-95 
                  The statistical analysis was carried by one way ANOVA followed by Dunnet’s 
―t test. P values <0.05 (95% confidence limit) was considered statistically significant, 
using Software Graph pad Prism 6.0 
7.4 ISOLATION AND CHARACTERISATION OF PHYTOCONSTITUENTS BY 
COLUMN CHROMATOGRAPHY  
                      Column chromatography is an isolation technique in which phytoconstituents 
are being eluted by adsorption.  The principle involved in this separation of constituents is 
adsorption at the interface between solid-liquid. The component must have various degree 
of affinity towards adsorbent and also reversible interaction to achieve successful 
separation. No two compounds are alike in above respect. Low affinity compound will 
elute first. Adsorbent used is silica gel. 
                      Ethanolic extract of Myristica malabarica was found to possess maximum 
phytoconstituents with potent sedative and hypnotic activity. An attempt was made to 
fractionate the ethanolic extract by column chromatography. 
COLUMN CHROMATOGRAPHY96: 
 Type of extract         : Ethanolic extract 
 Method          : Dry packing method 
 Packing material       : Silica gel G70-325 
PROCEDURE: 
                The ethanolic extract was subjected to Silica gel column chromatography for 
isolation of phytoconstituents.  
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                 An appropriate column sized 2.5 cm diameter and 60 cm length was used. It was 
washed with water and rinsed with acetone and dried completely. Little of pure cotton was 
placed at the bottom of column with help of a big glass rod. Solvent Hexane was poured in 
to the column 3/4th level. Before packing, ethanolic extract 10 gm was diluted with same 
solvent and thoroughly mixed with 30 g of graded silica gel. It was constantly mixed until 
it became free flow. When it reached at defined state it was slowly poured in to the column 
containing hexane solvent with slight movement of stirring by glass rod to avoid clogging. 
Once it got settled, little cotton was placed on top of silica gel extract mixture pack to get 
neat column pack. The knob at bottom was slowly opened to release the solvent. The elute 
was done using hexane, followed by hexne-ethyl acetate mixture and ethyl acetate-ethanol 
mixture. Each fraction were collected and analyzed quantitatively. Similar fractions were 
mixed together, allowed to evaporate to remove solvent.  
TLC97 
                As soon as the fraction eluted, it was analyzed by using readymade TLC plate 
with suitable mobile solvent according to the polarity of elute.  
SOLVENT 
              Methanol: Chloroform in 1: 9 ratio.  
OBSERVATION 
               The developed chromatogram was observed under UV, Fluorescence and also 
derivatised using detecting agent. 
CHARACTERISATION OF ISOLATED COMPOUND 
PHYSICAL EVALUATION: 
1. Physical properties of the isolated compounds are evaluated, such as 
 Colour 
 Nature 
 Solubility 
 Molecular weight 
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 Molecular formula 
 Melting point 
 Boiling point 
2. Further the isolated compounds were characterized by following Spectroscopic 
methods. Such as 
 IR Spectroscopy 
 Mass spectroscopy (GCMS) 
IR SPECTROSCOPY98 
              Infrared (IR) spectroscopy is one of the most common spectroscopic techniques 
used by organic chemists. The main goal of IR spectroscopic analysis is to determine the 
chemical functional groups in the sample. Different functional groups absorb characteristic 
frequencies of IR radiation. IR spectroscopy is an important and popular tool for structural 
elucidation and compound identification. The possible characteristic bands of the nucleus 
are 
                     1. 3540-3300 cm-1 N-H Stretching Vibration 
                     2. 3670-3230 cm-1 O-H Stretching Vibration 
                     3. 1690-1630 cm-1 C=N Stretching Vibration 
                     4. 2975-2840 cm-1 C-H Aliphatic Stretching Vibration 
                     5. 3100-3000 cm-1 C-H Aromatic Stretching Vibration 
MASS SPECTROSCOPY100-101 
             Mass Spectrometry is an analytic technique that utilizes the degree of deflection of 
charged particles by a magnetic field to find the relative masses of molecular ions and 
fragments.  
 Determining molecular mass 
 Finding out the structure of an unknown substance 
 Verifying the identity and purity of a known substance 
 Providing data on isotopic abundance. 
GC-MS102: 
          It is a combined technique, used for molecular weight determination. Gas 
chromatography and mass spectroscopy combined to form GC-MS. 
  
 
 
  
RESULTS 
&  
DISCUSSION 
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8. REULTS AND DISCUSSION 
8.1.  PHARMACOGNOSTICAL STUDIES: 
               Pharmacognostical studies play a key factor in establishing the authenticity of the 
plant material. The botanical identity of the seed was established by examining its 
anatomical features. 
              The results of the pharmacognostical studies are as follows. 
Organoleptic characters 
Nature  - yellowish coarse powder 
Colour  - Yellowish orange 
Odour   - Aromatic 
Taste  - Bitter 
Morphological Features: 
              Seed aril are oval or elliptical shaped and are 4-5cm in length and 2-3 cm in width. 
The thickness of the seed aril is mostly 0.5 to 1 cm. The seed are hard and brittle in nature. 
The seed aril is present in between endocarp and the sed. 
               The morphological features of the seed aril are tabulated below for a better and 
easy understanding. 
Table No. 2: Morphological features of Seed aril 
S.no Parameters Observation 
1 Size: 4-5 cm in length 
2 Shape: Ovular 
3 Colour: Yellowish orange 
4 Odour: Aromatic 
5 Taste Bitter. 
 
                                                                                                                                            Results and Discussion 
Department of Pharmacognosy, COP, MMC                                                53 | P a g e  
 
Fig. 13: Fresh fruit with seed aril 
 
Fig. 14: Dried Seed Aril 
 
                                                                                                                                            Results and Discussion 
Department of Pharmacognosy, COP, MMC                                                54 | P a g e  
MICROSCOPY:  
              The TS section are made by fixing the drug to the formalin and precisely sectioned 
used a microtome and stained. The characteristics of the T.S of seed are explained below 
Transverse section of Myristica malabarica seed aril:   
  The seed aril are hard and brittle in nature. The transverse section of the seed aril 
showed the presence of the epidermal cell, parenchymal cells, oil glands and vascular 
bundle.  
Epidermal cells:  
   The epidermal cells are present at the outer layer. They are arranged without any 
intracellular spaces. 
Parenchymatous cell:  
               Arranged horizontally along with the epidermal cells and oil glands and oil 
globules are arranged in these parenchymatous layer.  
Vascular bundle:  
               Xylem and Phloem are arranged found in the seed aril. Crystal sheath and calcium 
oxalate are present in the parenchymatous layer of the seed aril.  
 
  A- Starch grains, B- Vascular bundle,C- Epidermal cells and D- Parenchyma cells. 
Fig. 15: TS of Myristica malabarica 
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POWDER MICROSCOPY: 
                      Powder microscopy of the seed aril of Myristica malabarica was observed 
and it showed the presence of fibers, xylem vessels, stone cells and calcium oxalate, oil 
cells and starch grains were also observed. 
These features can be employed for inter specific identity of drugs.  
                  
       Fig. 16: Oil Globules         Fig. 17: Fibre 
     
Fig. 18: Cluster of stone cell    Fig. 19 : Calcium oxalate crystal 
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        Fig. 20: Vascular bundle                                                 Fig. 21: Starch grains 
HISTOCHEMICAL COLOUR REACTIONS: 
            Histochemical analysis is done in order to detect presence of phytoconstituents and 
their histology.  
            The Histochemical analysis showed the presence of Lignin, Starch and Tannin in 
xylem, Middle layer near oil globule and vascular bundle.  
Table 3:  Histochemical colour reactions of Myristica malabarica. 
Sno Chemicals Test for Nature of 
change 
Histology Degree of 
change 
1 Phloroglucinol + 
HCl 
Lignin Pink xylem + 
2 N / 50 Iodine 
Solution 
Starch Blue Middle layer 
near  
+ 
3 Dil. Ferric Chloride Tannin Black Vascular 
bundles 
+ 
4 Picric acid Protein No yellow 
colour 
-- - 
5 Dragendroff’s 
reagent 
Alkaloid No orange 
colour 
-- - 
Note: + -- Indicates the prescence, - indicates absence 
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PHYSICO-CHEMICAL CONSTANTS 
             Physicochemical parameters are mainly used in judging the purity and quality of 
the powdered drug. Ash values of a drug give an idea of the earthy matter or inorganic 
elements and other impurities present along with the drug. 
              Ash values are mainly used in judging the purity and quality of the drug is the 
indicative of contamination, substitution and adulteration. The total ash usually consists of 
carbonate, phosphate and silicates. Total ash, acid insoluble ash and water soluble ash were 
done and reported in the table below. 
Table No. 4: The Physicochemical analysis of the seed aril of Myristica malabarica. 
S.NO PHYSICO-CHEMICAL CONSTANTS RESULTS (%w/w) 
I ASH VALUE 
1. Total ash 3.26 ± 0.15 
2. Water soluble ash 0.72± 0.06  
3. Acid insoluble ash 0.89 ± 0.15 
4. Sulphated ash 1.00 ± 0.15 
II EXTRACTIVE VALUE 
1. Water soluble extractive 28.34 ± 1.44 
2. Alcohol soluble extractive 10.56 ± 0.19   
3. Ether soluble extractive 2.22 ± 0.12 
4 Nonvolatile ether soluble extractive 2.08±  0.14 
III Loss on drying 5.69 ± 0.19% 
IV Swelling index 1.5 ml 
V Foaming index NIL 
VI Volatile oil content 6% V/W 
Values are expressed as Mean ± SD, n=3 
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INORGANIC ELEMENTS AND HEAVY METAL ANALYSIS 
          Qualitative and quantitative estimation of inorganic metals were analyzed using 
Inductive coupled plasma analysis method and the results were tabulated as follows. 
Table No. 5: Qualitative estimation of inorganic elements of Myristica malabarica. 
S.No INORGANIC ELEMENTS OBSERVATIONS 
1. Aluminium + 
2. Chloride + 
3. Copper - 
4. Calcium + 
5. Iron - 
6. Borate + 
7. Potassium + 
8. Carbonate - 
9. Sulphates - 
10 Silver - 
11 Nitrate + 
 
Table No. 6: Quantitative estimation of inorganic elements of Myristica malabarica. 
S.NO INORGANIC 
ELEMENTS 
TOTAL AMOUNT         
(% W/W) 
1. Aluminium 0.018 
2. Chloride 0.044 
3 Calcium 0.032 
4. Borate 0.004 
5. Potassium 0.049 
6. Nitrate 0.011 
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Quantitative estimation of Heavy metals by ICP OES method 
           The quantification of the individual heavy metals was analyzed for the powdered 
mixture of Myristica malabarica by ICP-OES technique the following metals like arsenic, 
lead, cadmium were detected and quantified, results are given in the following table. 
Table No. 7: Quantitative estimation of Heavy metals 
                 The above observation showed that the material is within the limits as per WHO 
standard and it is safe to consume internally. 
8.2.  PHYTOCHEMICAL STUDIES 
EXTRACTION: 
               Extraction with the various solvent were performed, percentage yield and 
phytochemical analysis were done. The percentage yield of each extract are tabulated 
below. 
Table No. 8: Percentage yield of successive extracts. 
S.NO EXTRACT METHOD 
OF EXTRACTION 
PHYSICAL 
NATURE 
COLOUR YIELD 
(%W/W) 
1. Benzene Continuous Hot 
percolation method 
using Soxhlet 
apparatus 
Semi solid Orangish 
yellow 
8.5 
2. Ethanolic 
 
Semisolid and 
sticky 
Brownish 
yellow 
10.2 
3. Aqueous Hydro distillation 
using Clevenger’s 
apparatus 
Liquid and 
sticky 
Yellowish 
orange 
6.5 
S.No Element Results (ppm) Specification 
1. Mercury Not detected Not more than 0.5ppm 
2. Arsenic 0.023 Not more than 5.0ppm 
3. Lead 0.032 Not more than 10ppm 
4. Cadmium 0.001 Not more than 0.3ppm 
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PHYTOCHEMICAL ANALYSIS 
             The phytochemical analysis of various extracts were performed and presence of 
flavonoid, tannins, saponins and steroids were significant. 
Table No. 9: Qualitative Phytochemical analysis 
SNO TESTS POWDER BENZENE ETHANOL AQUEOUS 
1 Alkaloids 
- 
- - - 
2 Flavonoids + + ++ + 
3 Phytosterols + - + - 
4 Triterpenoid 
+ 
- + + 
5 
Tannins and 
phenolic 
compound 
+ 
- + + 
6 Saponins 
+ 
- + + 
7 
Gums and 
mucilage 
+ 
- + + 
8 Carbohydrates 
+ 
- + + 
9 Glycosides 
- 
- - - 
10 
Proteins & 
amino acids 
- 
- - - 
11 Steroids 
+ 
- + + 
12 
Fixed oils and 
Fats 
- 
- - - 
Note: + indicates presence, - indicates absence 
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QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
               The Myristica malabarica Lam., was found to contain various phytochemical 
constituents and hence it is desirable to quantify few of them in order to establish a standard 
to maintain its quality. Among them the estimation of total Flavonoids, Phenolic and 
Alkaloidal content in the ethanolic, aqueous and benzene extract are done.  
TOTLA FLAVONOID CONTENT 
             Total flavonoid content was determined and compared with that of standard and 
thus ethanolic extract was found to have higher absorbance than benzene and aqueous 
extracts. It is represented in table 
Table No. 10:  Determination of Total Flavanoid content 
Standard calibration curve for determination of Total Flavonoid Content 
 
Fig. 22: Total Flavonoid content 
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Total Flavinoid Content
Standard Benzene Ethanol Aqueous
  S.No Concentration 
(µg/ml) 
Absorbance(765nm) of extracts 
Standard Benzene Ethanolic Aqueous 
1. 20 0.07 0.04 0.05 0.04 
2. 40 0.10 0.07 0.09 0.06 
3. 60 0.13 0.10 0.12 0.09 
4. 80 0.16 0.13 0.15 0.11 
5. 100 0.20 0.15 0.18 0.14 
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T OTAL PHENOLIC CONTENT 
          Total phenolic content was determined and compared with that of standard and thus 
ethanolic extract was found to have higher absorbance than benzene and aqueous extracts. 
It is shown in Table  
Table No. 11: Determination of Total phenolic content 
StandardCalibration curve for determination of total Phenolic content 
 
Fig. 23: Total Phenolic Content 
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Total phenolic Content
Standard Benzene Ethanol Aqueous
  S.No Concentration 
(µg/ml) 
Absorbance(765nm) of extracts 
Standard Benzene Ethanolic  Aqueous 
1. 20 0.13 0.09 0.11 0.04 
2. 40 0.16 0.11 0.13 0.06 
3. 60 0.19 0.13 0.16 0.09 
4. 80 0.22 0.16 0.19 0.11 
5. 100 0.25 0.18 0.22 0.14 
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Total Alkaloid content 
             Total alkaloid content was determined and compared with that of standard and thus 
ethanolic extract was found to have higher absorbance than benzene and aqueous extracts. 
It is shown in Table  
Table No. 12:  Total alkaloidal content 
Standard Calibration curve for determination of total alkaloid content 
 
Fig. 24: Total Alkaloid Content 
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Total Alkaloid Content
Standard Benzene Ethanol Aqueous
  S.No Concentration 
(µg/ml) 
Absorbance(470nm) of extracts 
Standard Benzene Ethanolic Aqueous 
1. 20 0.15 0.06 0.10 0.03 
2. 40 0.17 0.08 0.12 0.05 
3. 60 0.19 0.11 0.13 0.07 
4. 80 0.21 0.14 0.15 0.13 
5. 100 0.24 0.16 0.18 0.16 
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           The Flavonoids, phenolic and alkaloids content present in the extract were 
determined quantitatively. 
Total Flavonoid, phenol and alkaloid content of extracts of Myristica malabarica are 
represented in table. 
Table No. 13: Determination of Total Phytochemical content 
FLUORESCENCE ANALYSIS 
                 Fluorescent analysis of powder and extracts were analyzed in day light and 
under UV of 265 nm and 365 nm.  
Table No. 14: Fluorescence characteristic of powdered samples at short UV and 
long UV. 
TREATMENT  DAY LIGHT  
SHORT UV (254 
nm)  
LONG UV (365 
nm)  
Drug  Pale white  Dark brown  Orange  
Drug + Water  Light yellow  Light yellow  Orange  
Drug + 1 N Hcl  Light yellow  Dark green  Pale yellow  
Drug + 1 N HNO3  Light yellow  Dark green  Brownish yellow  
Drug + 1 N H2SO4  Reddish brown  Blackish brown  Dark brown  
Drug + Acetic acid  Light yellow  Pale green  Yellowish brown  
Drug + 1N NaOH  Dark yellow  Greenish brown  Orange  
Drug + 1N NaOH  Dark yellow  Greenish brown  Orange  
Drug + 1 N KOH  Dark yellow  Greenish brown  Pale brown  
S.No EXTRACT TOTAL 
FLAVANOID       
CONTENT 
TOTAL 
PHENOLIC 
CONTENT 
TOTAL 
ALKALOID 
CONTENT 
1. Benzene 50.25 µg/mg 5.250µg/mg                       3.45 µg/mg 
2. Ethanol 70.42 µg/mg 8.375µg/mg                       5.31 µg/mg 
3 Aqueous 42.51 µg/mg 3.81 µg/mg 2.15 µg/mg 
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Drug + 1N  KOH  Dark yellow  Greenish brown  Pale brown  
Drug + Ammonia  Dark yellow  Dark green  Dark orange  
Drug + Iodine  Brownish orange  Brownish green  Reddish green  
Drug + Fecl3  Brownish green  Brownish green  Dark green  
Drug + Picric acid  Dark yellow  Dark green  Brownish green  
Florescence characteristics of the extracts of the seed aril of Myristica malabarica. 
Table No. 15: Fluorescence characteristic of extracts at short UV and long UV. 
EXTRACT DAY LIGHT 
SHORT UV (254 
nm) 
LONG UV (365 
nm) 
Hexane  Pale brown Reddish brown Brown  
Aqueous  Brownish black Blackish green Dark Brown 
Ethanolic Brown Reddish brown Brown 
TLC OF EXTRACTS:  
        Thin Layer Chromatogrphy of the various extracts were performed and Rf
 value was 
determined.  
Table No. 16: Thin layer chromatography of various extract. 
SNO EXTRACTS SOLVENT 
SYSTEMS 
NO OF 
SPOTS 
Rf value  
1 Benzene  Methanol : 
Chloroform 
1:9 
3 0.86 
0.81 
0.75 
2 Ethanolic Methanol : 
Chloroform 
1:9 
4 0.88 
0.85 
0.83 
0.81 
3 
 
Aqueous Methanol : 
Chloroform 
1:9 
2 0.74 
0.68 
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 Fig. 25: Benzene TLC                  Fig. 26: Ethanoli TLC     Fig. 27: Aqueous TLC 
              TLC of all the three extracts were run through various solvents. An effective 
separation was found in the Ethanol: Ethyl acetate: Water solvent system. Separation was 
incomplete when solvents for alkaloid, steroids and tannins were performed. It was found 
to contain flavonoids.  
HPTLC FINGER PRINT PROFILE 
HPTLC Finger print Data of Ethanolic Extract of Myristica malabarica Lam., 
           High performance thin layer chromatography (HPTLC) finger printing was 
performed with the ethanol extract of Myristica malabarica Lam., The chromatographic 
conditions were carried as detailed in material and method of this study. There were 10 
peaks observed with different Rf Values and different heights.  
Table No. 17: Solvent system of HPTLC analysis 
EXTRACT SOLVENT 
Ethanolic extract Hexane : Ethyl acetate : Chloroform : 
Toulene : Methanol : Formic acid   
(2: 2 : 1: 4: 0.5: 0.5) 
Derivatizing agent: 10% Anisaldehyde 
sulphuric acid 
Lamp: Tungsten 
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Fig. 28: HPTLC Finger Print Data 
 
Fig. 29: HPTLC chromatogram for Myristica malabarica Lam 
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Fig. 30: Histogram for Myristica malabarica Lam HPTLC data 
Table No. 18: HPTLC profile of extracts 
S.No Rf Heigh Area Lamda Max 
1 0.10 19.6 342.8 737 
2 0.11 15.2 131.4 800 
3 0.17 2.4 28.6 507 
4 0.19 3.6 88.3 507 
5 0.25 9.7 156.7 507 
6 0.27 9.0 153.5 507 
7 0.33 0.9 25.0 507 
8 0.44 1.5 34.5 507 
9 0.52 7.8 382.1 507 
10 0.74 3.3 124.7 507 
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8.3 PHARMACOLOGICAL STUDIES 
8.3.1 ANTIOXIDANT ACTIVITIES 
                 A number of studies indicates that oxidative stress is also a factor for sleep 
disorder which disrupts the GABA receptor binding activity which is essential for sleep. 
GABA binding proteins are inhibited by free radicals. Likewise, there are numerous studies 
which have examined the positive benefits of antioxidants linked to sleep disorder. In 
addition, the antioxidant potential of a compound can be attributed to its radical scavenging 
ability and total antioxidant activity. In order to determine the ability of the plant extracts 
to serve as antioxidants, two activities were measured; ability to scavenge DPPH and 
Hydrogen Peroxide Scavenging assay. 
DPPH radical scavenging activity: 
                 Various extracts were studied for its anti-oxidant activity using 1, 2-diphenyl-2-
picryl hydrazyl radical (DPPH). Results are discussed below. 
Table No. 19: DPPH Radical Scavenging activity of various extract 
S.No Concentration 
(µg/ml) 
% Inhibition  
     Standard   
 (Butylated 
hydroxyl 
Toulene ) 
Benzene 
extracts 
Ethanolic 
extracts 
Aqueous 
extracts 
1. 20 54.16 34.43 48.94 21.34 
2. 40 63.51 46.32 55.86 31.17 
3. 60 77.11 51.54 69.18 38.36 
4. 80 80.95 62.34 75.95 47.32 
5 100 93.36 73.34 89.87 52.45 
IC50 (µg/ml) 10 36 24 61 
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Fig. 31: DPPH Radical Scavenging activity of various extract 
 
                     The DPPH is a stable free radical which produced deep purple colour by 
accepting the proton from any proton donor substance and widely used to test free radical 
scavenging effect. The reduction of DPPH decreases its absorbance at 517 nm due to colour 
change. The ethanolic extract of Myristica malabarica showed IC50 value (µg/ml) of 24 
whereas Benzene and aqueous extract showed Ic50 (µg/ml) value 36 and 61 respectively. 
Whereas the IC50 (µg/ml) value of standard BHT was 10. Ethanolic extracts of Myristica 
malabarica is found to produce good scavenging activity in comparison to standard. 
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HYDROGEN PEROXIDE RADICAL SCAVENGING ACTIVITY:  
 The benzene, ethanol and aqueous extracts were subjected to hydrogen peroxide 
radical scavenging assay and the results are tabulated below in Table 2 & Fig 2. 
Table No. 20: Hydrogen peroxide Radical Scavenging activity of various extract 
Sno Concentration % inhibition 
Standard 
(Ascorbic 
acid) 
Aqueous 
extracts 
Benzene 
extracts 
Ethanolic 
extracts 
1 20 µg/ml 35.14 12.34 21.71 32.43 
2 40 µg/ml 42.34 24.54 34.23 41.65 
3 60 µg/ml 58.84 28.45 41.43 51.81 
4 80 µg/ml 75.32 32.54 49.34 59.65 
5 100 µg/ml 89.74 38.56 54.43 63.56 
IC 50 (µg/ml) 37 127 68 54 
 
 
Fig. 32: Hydrogen peroxide Radical Scavenging activity of various extract 
                 The ability of the extract to scavenge hydrogen peroxide was determined in this 
method. Absorbance is measured at 230 nm and IC50 (µg/ml) value has been calculated and 
was found to be 54 for Ethanolic extract, whereas Benzene and Aqueous extract showed 
the IC50 –value (µg/ml) of 68 and 127 respectively. IC50 value of standard Ascorbic acid 
was 37. 
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              Ethanolic extract of Myristica malabarica was found to produce good 
scavenging activity in comparison to standard.  
               The below bar diagram repesents the IC50 value for different extracts using 
DPPH and Hydrogen peroxide scavenging method. The lower the IC50value the higher 
the antioxidant activity. From the result Ethanolic extract has the lowest value, Benzene 
has moderate value and aqueous has highest IC50 value. Therefore it is evident that 
Ethanolic extract has high antioxidant property where Aqueous extract has the lowest 
antioxidant property. 
 
 
 
Fig. 33: IC50 values of antioxidant activity of various extract 
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8.3.2 IN-VIVO STDIES 
EVALUVATION OF SEDATIVE ACTIVITY BY SPONTANEOUS LOCOMOTOR 
ACTIVITY 
                The three extracts of Myristica malabarica (Benzene, Ethanolic and Aqueous) 
are subjected for Sedative activity by Actophotometer method. The number of crossing by 
the mice before and after the drug administration is noted and the results are listed below. 
Table No. 21: Sedative activity using actophotometer 
Mean ±SEM; n=6 in each group; One way ANOVA 
 
 
 
 
 
S.No 
 
 
Group 
No of Crossings Before and after drug 
adminstration 
Before  30mins after 60mins after 
1 Control (1% tween 80) 252.43±8.21 249.69±7.32 251.62±2.10 
2 Standard (Diazepam) 241.21±6.15 86.53±5.74 104.30±4.91 
3 Benzene extract 
(400mg/kg) 
239.56±4.54 107.82±4.09 113.41±5.72 
4 Ethanolic extract 
(400mg/kg) 
250.08±3.11 92.29±5.39 108.71±2.60 
5 Aqueous extract 
(400mg/kg) 
247.11±5.56 121.19±6.17 134.27±7.61 
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Table No. 22: Percentage decrease in Locomotor activity 
 
S.No 
 
Group 
% Decrease in 
locomotor activity 
compared to standard  
1 Control (1% tween 80) 36.21 
2 Standard (Diazepam) 100 
3 Benzene extract 
(400mg/kg) 
86.36 
4 Ethanolic extract 
(400mg/kg) 
95.01 
5 Aqueous extract 
(400mg/kg) 
74.83 
 
 
 
Fig. 34: Percentage decrease in locomotor activty 
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               The three extracts was subjected to sedative activity which is determined by 
spontaneous locomotor activity in mice and the results show that all three extracts has 
significant sedative activity.  
                 The Ethanolic extract has the highest activity of 95.01%, Benzene extract has 
moderate activity of 86.36 % and the least active is aqueous extract has 74.83% sedative 
activity when compared to the standard drug Diazepam. Ethanolic extract has the nearest 
value to the standard hence it has the highest hypnotic activity among extracts 
            All values are expressed as Mean ±SD and datas were analysed by One Way 
Annova followed by Dunnett’s test a-P<0.05: b-P<0.01 when compared with standard 
group. 
 
EVALUVATION OF HYPNOTIC ACTIVITY BY POTENTIATION OF 
HEXOBARBITAL INDUCED SLEEP TIME 
                 The three extracts of Myristica malabarica (Benzene, Ethanolic and Aqueous) 
are screened for hypnotic activity. The standard drug and extracts were given 30 mins 
before the administration of Hexobarbital. The onset of sleep and waking is determined by 
righting reflex of the mice used. The results are noted and listed below in tabular column 
and in graphical bar representation for a better understanding. 
Table No. 23: Potentiation of Hexobarbital induced sloe time for Hypnotic activity 
S.no Group  Onset of  sleep    
(min) 
Duration of 
sleep (min) 
% Increase in 
sleep compared 
to control 
1 Control 5.25±6.28 95.57±7.21 - 
2 Standard 3.19±7.11 124.32±8.22 31.57 
3 Benzene 
(400 mg/kg) 
4.14±11.45 102.41±6.42 7.36 
4 Ethanolic 
(400 mg/kg) 
3.52±5.24 118.27±9.51 24.21 
5 Aqueous 
(400 mg/kg) 
4.49±4.51 98.11±4.56 3.15 
Mean ±SEM; n=6 in each group; One way ANOVA 
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Fig. 35: Percentage increase in sleep time. 
                      All three extracts has significant Hypnotic activity. The Ethanolic extract has 
the highest activity of 24.21%, Benzene extract has moderate activity of 7.36 % and the 
least active is aqueous extract has 3.15% hypnotic activity when compared to the standard 
drug Diazepam which has 31.57% potentiation of hexobarbital induced sleep time. 
Ethanolic extract has the nearest value to the standard hence it has the highest hypnotic 
activity among extracts. 
 
                    All values are expressed as Mean ±SD and datas were analysed by One Way 
Annova followed by Dunnett’s test a-P<0.05: b-P<0.01 when compared with standard 
group. 
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ISOLATION OF COMPOUND BY COLUMN CHROMATOGRAPHY: 
A).COLUMN CHROMATOGRAPHY 
              The eluates obtained from silica gel column chromatography of ethanolic extract 
with different fraction are tabulated in table 
 
Table No. 24: Fractionation of ethanolic extract 
ELUENT SOLVENT RATIO FRACTION 
n-Hexane  100% 0 
Ethyl acetate: 
Hexane 
10:90 1-3 
Ethyl acetate: 
Hexane 
20:80 4-6 
Ethyl acetate: 
Hexane 
30:70 7-11 
Ethyl acetate: 
Hexane 
40:60 12-16 
Ethyl acetate: 
Hexane 
50:50 17-21 
Ethyl acetate: 
Hexane 
60:40 22-26 
Ethyl acetate: 
Hexane 
70:30 27-31 
Ethyl acetate: 
Hexane 
80:20 32-36 
Ethyl acetate: 
Hexane 
90:10 37-41 
Ethyl acetate 100% 42-46 
Ethyl acetate: 
Ethanol 
90:10 47-50 
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Ethyl acetate: 
Ethanol 
80:20 51-54 
Ethyl acetate: 
Ethanol 
70:30 55-58 
Ethyl acetate: 
Ethanol 
60:40 59-62 
Ethyl acetate: 
Ethanol 
50:50 63-66 
Ethyl acetate: 
Ethanol 
40:60 67-70 
Ethyl acetate: 
Ethanol 
30:70 71-74 
Ethyl acetate: 
Ethanol 
20:80 75-78 
Ethyl acetate: 
Ethanol 
10:90 79-82 
Ethanol 100% 83-86 
 
 
Thin layer chromatography of isolated fractions  
Solvent system:  
Methanol: Chloroform (1:9)  
 
Table No. 25: Thin layer chromatography of isolated fractions 
SNO FRACTION COMPOUND Rf VALUE 
1 0 - - 
2 1-3 - - 
3 4-6 - - 
4 7-11 - - 
5 12-16 - - 
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6 17-21 - - 
7 22-26 - - 
8 27-31 - - 
9 32-36 - - 
10 37-41 - - 
11 42-46 - - 
12 47-50 C1 0.7 
13 51-54 C1 0.7 
14 55-58 C1 0.7 
15 59-62 C1 0.7 
16 63-66 C1 0.7 
17 67-70 C2 0.8 
18 71-74 C2& 3 0.8 
0.85 
19 75-78 C2&3 0.8 
0.85 
20 79-82 C2&3 0.8 
0.85 
21 83-86 C2&3 0.8 
0.85 
 
Characterization of isolated compound 
Physical properties of the isolated compounds are evaluated, such as 
 Colour   : Orangish yellow 
 Nature   : Solid 
 Solubility   : Soluble in Ethanol and Chloform 
 Molecular weight             : 358.434. 
 Molecular formula             : C21H26O5 
 Boiling point  :263.4340C 
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TLC of Compound 1 
 
Fig. 36: TLC of Compound 1 
Mobile phase: Methanol - Chloroform(1:9) 
Stationary Phase: Silica gel G 
No of spots: 1 
Rf value: 0.8 
 
 
 
Spectral analysis: 
              The compound C1 obtained from ethanolic extract have identified and spectral 
datas were depicted in below informations.  
 
IR analysis  
 IRυcm-1: KBr Pellet method. 
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Table No. 26: IR Interpretation 
WAVE NUMBER INTENSITY TYPE 
3390 Broad O-H stretching 
2926 Sharp Benzene 
2090 Weak band C-H stretching in CH2 and CH3 
2856 Sharp  C-H Stretching in CH3 
1900-1600 Moderate >C= O Carbonyl group 
1650-1450 Sharp Aromatic C=C stretching  
1451 Sharp  C-H stretching 
1382 Sharp C-H def Methyl 
1272  Moderate Phenol 
1077 Moderate  C-O-C stretching 
775 Sharp Ortho substituted benzene 
970-700 Sharp -CH=CH2 
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IR Spectral Analysis for compound C1 
 
Fig. 37: IR analysis of Compound 1 
FTIR Spectral Analysis for compound C1 
 
Fig. 38: FTIR analysis of Compound 1 
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GCMS analysis. 
              The GCMS analysis revealed the molecular structure through the following datas 
Table No. 27: GCMS analysis of Compound 1 
# RT Scan Height Area Area % Norm % 
1 16.579 2755 68,070,480 40,475,748.0 16.009 32.44 
2 17.179 2875 50,544,136 24,992,804.0 9.885 20.03 
3 21.441 3727 35,927,156 7,395,712.0 2.925 5.93 
4 23.326 4104 861,835,968 124,767,248.0 49.347 100.00 
5 23.662 4171 83,498,344 9,893,860.0 3.913 7.93 
6 25.587 4556 53,232,544 12,720,513.0 5.031 10.20 
7 26.668 4772 34,031,532 9,056,013.0 3.582 7.26 
8 27.038 4846 41,355,216 8,806,730.0 3.483 7.06 
9 27.748 4988 37,612,764 14,727,990.0 5.825 11.80 
 
 
Fig. 39:  GCMS Analysis of Compound 1 
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Fig. 40: GCMS Analysis of Compound 1 with structure 
                 From the data obtained through IR, FTIR and GCMS analysis the isolated 
compound can be assumed to be Malabaricone C with IUPAC name as (2,6-
dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one. 
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9. SUMMARY AND CONCLUSION 
     Modern lifestyle has a great impact on people health and Sleep disorder is one 
of the most common disease that affects 1/5 of the population in India. Most of the drugs 
that is currently prescribed has undesirable side effects. Herbal medicines have greater 
potential in therapeutic medicine and has more patient compatibility with less desirable 
side effects. Herbal medicine is a major component in all indigenous traditional medicine 
and a common element in Ayurveda, Siddha, Homeopathy and Naturopathy systems of 
medicine. Hence the present study is an attempt to evaluate sedative and hypnotic activity 
on the seed aril of the plant Myristica malabarica Lam., 
 
9.1 PHARMACOGNOSTICAL STUDIES  
 The pharmacognostical studies on the seed aril of Myristica malabarica Lam., 
was carried out, which showed the unique features of the bark which is used to 
differentiate it from other species. 
 Macroscopical studies states the characteristic features of seed aril such as 
colour, shape, length and width, nature of the drug, smell, taste and other 
morphological characters has been well studied. 
 Microscopical analysis of the seed aril along with TS showed the presence of oil 
globules, fibers, sclerides, calcium oxalate crystals, starch grains, etc, which can 
be as a standard for identification.  
 Physicochemical studies various physiochemical constants were evaluated such 
as ash values, extractive values, volatile oil content, foreign organic matter, 
foaming index, swelling index and loss on drying. 
            These pharmacognostical parameters evaluated are useful for the establishment 
of standards of seed aril which is essential for its future references such as identity and 
purity of the drug. 
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9.2 PHYTOCHEMICAL STUDIES 
 In phytochemical study, the powdered drug was successively extracted with 
benzene and ethanol by using soxhlet apparatus. Aqueous extraction is done by 
Clevenger’s distillation apparatus. The percentage yield for benzene, ethanolic 
and aqueous extracts are 8.5, 10.2 and 6.5 % w/w. 
 Preliminary phytochemical investigation was done for the powdered drug and 
all the extracts. It was found to contains flavonoids, triterpenoids, alkaloids, 
phenolic compounds, steroids, etc,. 
 Quantitative estimation of the phytoconstituents is carried out for alkaloids, 
phenolic compounds and flavonoids.  
 Fluorescence analysis was done to find out characteristic fluorescent substance 
present in the powdered bark and all the extracts, and no fluorescent substance 
was found. 
 High performance thin layer chromatography (HPTLC) was performed with 
ethanolic extract of Myristica malabarica Lam., and the finger print showed the 
presence of 10 peaks helpful in the quantitative and qualitative identification of 
phytoconstituents. 
 
9.3 PHARMACOLOGICAL ACTIVITY 
In vitro studies 
 All the extracts were subjected to in-vitro antioxidant activity using DPPH and 
hydrogen peroxide scavenging method. All the extracts showed significant 
antioxidant activity and the ethanolic extract showed the maximum antioxidant 
potential. Therefore all the extracts were chosen for the in-vivo studies. 
In vivo studies 
 In-vivo sedative and hypnotic activity was carried out for all the extract in Swiss 
albino mice by using spontaneous locomotor activity and potentiation of 
hexobarbital induced sleep time. The dose of the extracts is fixed to 400mg/kg 
through oral route. 
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 In-vivo sedative activity is evaluated by spontaneous locomotor activity using 
actophotometer. All the extracts showed sedative activity in which ethanolic 
extract has the highest activity. The percentage decrease in locomotor activity of 
the Ethanolic, Benzene and Aqueous extracts are 95.01, 86.36 and 74.83 when 
compared to the standard drug diazepam. 
 
 In-vivo hypnotic study is evaluated by potentiation of hexobarbital induced sleep 
time. All the extracts showed hypnotic activity in which ethanolic extract has the 
highest activity. The percentage increase in sleep time of the Ethanolic, Benzene 
and Aqueous extracts are 24.21, 7.36 and 3.15 when compared to the control 
drug hexobarbital. 
 
9.4 ISOLATION AND IDENTIFICATION 
 The active constituents of the ethanolic extracts are isolated using column 
chromatography and spectral studies were done on the isolated compound. 
 
 The IR, FTIR and GCMS spectral analysis data the compound was useful in 
identification of the compound as Malabaricone C with IUPAC name as (2,6-
dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one. 
 
               From the above mentioned reports it can be concluded that the standards 
generated will be useful in proper identification of plant and also to differentiate it from its 
closely related species and adulterants with the support of Pharmacognostical, 
Phytochemical screening, in-vitro and in-vivo studies.  
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CONCLUSION          
               The ethanolic extract showed a significant sedative and hypnotic activity than the 
benzene and aqueous extracts. This may be due to one or more phytoconstituents like 
flavonoids present in the extract and it can be due to the isolated compound Malabaricone 
C with IUPAC name as (2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one..  
                  Further research work has to be carried out to standardize the isolated molecule 
Malabaricone C and which can further screened for preclinical and clinical studies for 
sedative and hypnotic activity. 
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Myristica malabarica: A comprehensive review 
 
Prem Kumar Chelladurai and Radha Ramalingam 
 
Abstract 
The plant Myristica malabarica Linn belongs to the family Myristicaceae. This plant is endemic to India 
& found commonly in Western Ghats. It is an important medicinal plant commonly known as Malabar 
nutmeg, rampatri or Bombay mace. Different chemical constituents such as Malabaricones, 
Malabaricanal, Isoflavones and many other compounds are isolated and tested for pharmacological 
activity. Myristica malabarica is traditionally used for anti-ulcer, sedatives hypnotics, antimicrobial, 
nematicidal and as anti-inflammatory. This review has summarized to recent scientific findings of 
Myristica malabarica’s phytochemistry, pharmacological activities of the plant. 
 
Keywords: Myristica malabarica, Malabaricones, sedative, hypnotics, anti-ulcer, antimicrobial 
 
Introduction 
Myristica malabarica is commonly called as Malabar nutmeg or kaatuhjathi. It is native to 
India found widely in western ghat hills. Myristica malabarica seed and seed aril is used as 
spice in Indian foods. They enhance the taste and aromatic flavor of the food. Recent scientific 
studies proved their biological activity according to their traditional claims. They are now 
known to possess Gastroprotective, Antipromastigote, Antioxidant, Antifungal, Nematicidal, 
Antiproliferative, Leukemic and Solid tumor.  
 
Plant Description 
Myristica malabarica Lam. (Myristicaceae) is a perennial tree about 25m tall. It is endemic to 
India and found widely distributed in Western Ghats forest region. Now it is a vulnerable 
species according to IUCN red list. Hence it must be preserved. 
 
Plant Taxonomy 
Kingdom  : Plantae 
Super division : Angiosperms 
Phylum   : Tracheophyta 
Class   : Magnoliopsida 
Order    : Mangoliales 
Family    : Myristicaceae 
Genus   : Myristica  
Species   : Myristica malabarica  
 
Synonyms 
Myristica dactyloides Wall 
Myristica notha Wall 
Myristica tomentosa J.Grah 
Palala malabarica Kuntze  
 
Common Names 
Malabar nutmeg, false nutmeg, Bombay mace. 
 
Vernacular Names 
Hindi  : Ramptri, Bambay-jayphal. 
Kannada : Kanage, Doddajajikai. 
Malayalam : Ponnampoovu, Kottappannu, Pathiripoovu, Panampalka. 
Sanskrit  : Bandhukapushpa, Gostani. 
Tamil  : Colaivenkai, Kattujatikkai. 
Telugu  : Adavijaikaya, Adividzajikaya. 
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Habit and Habitat 
It is a large 15-25 mts tall perennial tree found evergreen 
forests upto 800mts. It is a swamp and lowland forest habitat 
tree. Large trunks with greyish black color. Flowering and 
fruiting season starts at feb-aug month. It is vulnerable species 
listed according to ICUN list due to drainage of swamp 
forests for agricultural purposes. 
 
Ethano Medicinal Uses 
The plant Myristica malabarica is traditionally used as 
medicine and spices in food. The aril is used as febrifuge, 
cooling, expectorant. In Ayurveda, aril is used for many 
conditions related to vata such as, fever, bronchitis, cough and 
burning sensation. The fat extracted from seed is used to treat 
indolent ulcers, analgesics and for rheumatism. In Ayurveda, 
for disorders in vata seed fat is used for myalgia, sprains and 
sores. The plant is also used for anti-inflammatory, Analgesic, 
anti-ulcer, sedative, hypnotic, and antimicrobial actions. 
 
Phytochemical Constituents 
The plant Myristica malabarica was found to contain various 
phytoconstituents such as Isoflavones, Diarylnonanoids which 
consists of Malabaricones A-D, Tannins and several other 
phytochemicals are also considered to be present in the plant. 
A brief study of phytoconstituents is needed for this plant. 
 
Isoflavones 
The heartwood of Myristica malabarica is found to have 
isolation of several isoflavones such as 7, 4'-dimethoxy-5-
hydroxyisoflavone, biochanin A, prunetin and a rare alpha-
hydroxydihydrochalcone. 
 
Diarylnanoids 
The plant is found to consist of different type of 
Diarylnonanoids which are commonly called as 
Malabaricones. Myristica malabarica contains four 
Malabaricones A, B, C and D. These malabaricones proved 
pharmacologically for various activity.  
 
Tannins 
From the investigation of the heart wood a tannin 1, 3-
diarylpropanol is extracted. 
 
Pharmacognostical Review 
Morphology 
Height: 25 m tall. 
 
 
 
Trunk & Bark: Bark greenish-black, smooth, blaze reddish.  
 
 
Branches and branchlets: Branches- horizontal, Branchlets- 
subtree, glabrous.  
Exaduates: Sap red from cut end of bark, profuse. 
  
 
 
Leaves: Leaves simple, alternate, distichous; Petiole 1-1.5cm 
long, caniculate above glabrous, lamina 9.5-22*3.7-10 cm, 
elliptic or elliptic oblong, apex acute or sub-acute, base 
acuteor attenuate, margin entire, glossy above, glabrous and 
glaucous beneath, coriaceous; mid rib raised above. 
 
 
 
Inflorescence / Flower: Flowers unisexual, uroceolate, white; 
male flower numerous in number and smaller than female 
flowers, in auxillary cymes; female flowers in umbels, 5-6 
flowered. 
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Fruit and seed: Capsule 5-7.5*1.8-3.5, oblong, pubescent; 
seed one, Aril covering the seed yellow and laciniate. 
 
 
 
Pharmacological Review 
Anti-cancer activity 
Efficient and sensitive LC-MS/MS methods have been 
developed for the rapid screening and determination of 
bioactive compounds in fruit parts Myristica malabarica. 
Moreover, in vitro antiproliferative activity of 
these Myristica species was evaluated against five human 
cancer cell lines A549, DLD-1, DU145, FaDu and MCF-7 
using SRB assay. Evaluation of in vitro antiproliferative 
activity revealed potent activity in Myristica malabarica.  
 
Anti-diabetic activity 
The extract of Myristica malabarica is assayed for in vitro 
insulin secretion studies on islets of langerhans at 
concentration of 1mg/ml. the results were promising and 
showed dose dependent insulin secretion. Regular use of these 
spices may prevent postprandial rise in glucose levels through 
inhibition of intestinal alpha-glucosidase and may maintain 
blood glucose level through insulin secretagogue action. 
 
Anti-Fungal activity 
Methanol extract of fruit rinds of Myristica malabarica 
exhibited potent antifungal activity against phytopathogenic 
fungi such as rice blast, tomato late blight, wheat leaf rust and 
red pepper anthracnose. The compounds exhibited antifungal 
activity are isolated and found out to be Malabaricones A, B 
and C. 
 
Anti-Microbial activity 
Aqueous and Methanolic extract of Myristica malabarica is 
assayed for their activity against multi-drug resistant 
Salmonella typhi. moderate Antimicrobial activity was shown 
by the methanolic extract of the plant Myristica malabarica.  
 
Nematicidal activity 
The fruit rinds of Myristica malabarica are extracted with 
methanol. The extract is subjected to nematicidal activity 
against the Bursaphelenchus xylophilus at a concentration of 
1000 micro gram per ml and it is found to be very effective 
agaist the nematode. Studies show that malabaricones present 
in the plant Myristica malabarica is responsible for 
nematicidal activity. 
 
Anti-Oxidant activity 
The 1, 1-dipheny l-2-picrylhydrazyl (DPPH) assay of the 
ether, methanol, and aqueous extracts of the spice Myristica 
malabarica (rampatri) revealed the methanol extract to possess 
the best antioxidant activity. Column chromatography of the 
methanol extract led to the isolation of a new2-acylresorcinol 
and four known diarylnonanoids of which the diarylnonanoid, 
malabaricone C, showed the maximum DPPH scavenging 
activity. Malabaricone C could prevent both Fe (II)- and 2,2'-
azobis (2-amidinopropane) dihydrochloride-induced lipid 
peroxidation (LPO) of rat liver mitochondria more efficiently.  
 
Anti-Promastigote activity 
This study was undertaken to evaluate the antileishmanial 
activity of the fruit rind of Myristica malabarica that is used 
as a spice and is also credited with medicinal properties. The 
antipromastigote activity of different extracts/fractions of M. 
malabarica and its constituent diarylnonanoids were evaluated 
in Leishmania donovani promastigotes (MHOM/IN/83/AG83) 
using the MTS-PMS assay. Preliminary screening of the ether 
extract (R1) with its crude methanol fraction (R2) and two 
fractions (R3 and R4) revealed that R2 had potent 
leishmanicidal activity (IC(50) 31.0 microg/mL). Methanol 
extract of M. malabarica, especially its constituent 
compounds, Mal A and Mal B, have promising 
antileishmanial activity. 
 
Anti-ulcer activity 
The healing activity of the methanol extract of the spice 
rampatri, Myristica malabarica, (RM) and omeprazole against 
indometacin-induced stomach ulceration has been studied in a 
mouse model. Treatment with RM (40 mg kg(-1) per day) and 
omeprazole (3 mg kg(-1) per day) for 3 days could effectively 
heal the stomach ulceration, as revealed from the ulcer indices 
and histopathological studies. Compared with the ulcerated 
group, treatment with RM and omeprazole for 3 days reduced 
the macroscopic damage score by approximately 72% and 
76%, respectively (P<0.001), establishing the efficacy of RM. 
The healing capacities of RM and omeprazole could be 
attributed to their antioxidant activity as well as the ability to 
enhance the mucin content of the gastric tissues. Furthermore, 
RM improved the mucin level beyond the normal value, while 
omeprazole restored it to near normal. 
 
Conclusion 
Myristica malabarica a native plant of India has many 
medicinal properties. This present review is concerned mainly 
on the description, pharmacognostic features, phytochemical 
constituents and pharmacological activity. The major 
phytochemical constituents present in this plant which is 
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responsible for various pharmacological activity are 
Malabaricones A-D, and Isoflavones. The fruits, seeds, aril, 
bark and other parts of the plant extractives is found out to 
have various pharmacological activities like anti-cancer, 
nematicidal, anti-fungal, anti-bacterial, anti-ulcer, anti-
oxidant, anti-diabetic and anti-promastigote. Myristica 
malabarica is a resource of various phytochemical 
constituents which can be used for medicinal proprety. Hence 
further investigation is required for this plant to discover 
various medicinally potential compounds for the benefit for 
mankind. 
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